Molecular variability of Meningococcal antigens in carriage and disease strains and in other Neisseria species by Muzzi, Alessandro <1972>
Alma	  Mater	  Studiorum	  –	  Università	  di	  Bologna	  	  	  	  DOTTORATO	  DI	  RICERCA	  IN	  	  
Biologia	  Cellulare	  e	  Molecolare	  	  Ciclo	  XXVI	  	  Settore	  concorsuale	  di	  afferenza:	  05/E2	  -­‐	  BIOLOGIA	  MOLECOLARE	  Settore	  scientifico	  disciplinare:	  BIO/11	  -­‐	  BIOLOGIA	  MOLECOLARE	  	  TITOLO	  TESI	  	  Molecular	  variability	  of	  Meningococcal	  antigens	  in	  carriage	  and	  disease	  strains	  and	  in	  other	  Neisseria	  species	  	  Presentata	  da:	  Alessandro	  Muzzi	  	   	  
Coordinatore	  Dottorato	  Chiar.mo	  Prof.	  Vincenzo	  Scarlato	  	  
Relatore	  Chiar.mo	  Prof.	  Vincenzo	  Scarlato	  
	   	  Esame	  finale	  anno	  2014	  
	  	  	  	  
2	  
	   	  
	  	  	  	  
3	  
	  
Table	  of	  Contents	  
Table	  of	  Contents	  ...................................................................................................................	  3	  
Outline	  ..................................................................................................................................	  5	  
Chapter	  1.	   Conservation	  of	  Meningococcal	  antigens	  in	  the	  genus	  Neisseria	  ........................	  7	  1.1	   Abstract	  ...........................................................................................................................................................	  7	  1.2	   Introduction	  ..................................................................................................................................................	  8	  1.3	   Methods	  ........................................................................................................................................................	  10	  
1.3.1	   Phylogenetic	  analysis	  of	  the	  Neisseria	  genus.	  ..........................................................................	  10	  
1.3.2	   Estimate	  of	  the	  recombination	  and	  mutation	  rate.	  ...............................................................	  10	  
1.3.3	   Genome	  sequences.	  ...............................................................................................................................	  10	  
1.3.4	   Genome	  alignments	  and	  phylogenetic	  analysis	  of	  the	  sequenced	  strains.	  ...................	  11	  
1.3.5	   Genome	  annotation.	  ............................................................................................................................	  11	  
1.3.6	   Criteria	  for	  genes	  presence/absence.	  ...........................................................................................	  11	  
1.3.7	   Phylogenetic	  analysis	  of	  fHbp,	  nhba	  and	  nadA.	  .......................................................................	  12	  
1.3.8	   Identification	  of	  recombination	  events.	  ......................................................................................	  12	  1.4	   Results	  ...........................................................................................................................................................	  12	  
1.4.1	   Phylogeny	  of	  the	  genus	  Neisseria.	  .................................................................................................	  12	  
1.4.2	   Conservation	  of	  fHbp	  ...........................................................................................................................	  17	  
1.4.3	   Conservation	  of	  NHBA	  ........................................................................................................................	  25	  
1.4.4	   Conservation	  of	  NadA	  .........................................................................................................................	  30	  
1.4.5	   Conservation	  of	  GNA1030	  .................................................................................................................	  32	  
1.4.6	   Conservation	  of	  GNA2091	  .................................................................................................................	  34	  1.5	   Discussion	  and	  conclusions	  .................................................................................................................	  36	  
Chapter	  2.	   Conservation	  of	  Meningococcal	  antigens	  in	  carrier	  and	  pathogenic	  isolates	  of	  N.	  
meningitidis	  collected	  in	  the	  Czech	  Republic	  in	  1993.	  ...........................................................	  39	  2.1	   Abstract	  ........................................................................................................................................................	  39	  2.2	   Introduction	  ...............................................................................................................................................	  40	  2.3	   Methods	  ........................................................................................................................................................	  42	  
2.3.1	   Isolates	  panel	  ..........................................................................................................................................	  42	  
2.3.2	   Serogrouping	  and	  molecular	  typing	  ............................................................................................	  42	  
2.3.3	   Data	  Analysis	  ..........................................................................................................................................	  43	  2.4	   Results	  ...........................................................................................................................................................	  44	  
2.4.1	   Czech	  Republic	  carriage/disease	  strain	  panel	  .........................................................................	  44	  
2.4.2	   Variability	  of	  fHbp,	  NadA,	  and	  NHBA	  ..........................................................................................	  47	  
2.4.3	   fHbp	  ............................................................................................................................................................	  47	  
2.4.4	   NHBA	  ..........................................................................................................................................................	  58	  
2.4.5	   NadA	  ...........................................................................................................................................................	  60	  
2.4.6	   Variability	  of	  PorA	  and	  FetA	  variable	  regions	  .........................................................................	  61	  2.5	   Discussion	  and	  conclusions	  .................................................................................................................	  62	  
Chapter	  3.	   An	  analysis	  of	  the	  sequence	  variability	  of	  meningococcal	  fHbp,	  NadA	  and	  NHBA	  
over	  a	  50-­‐year	  period	  in	  the	  Netherlands.	  ............................................................................	  65	  3.1	   Abstract	  ........................................................................................................................................................	  65	  
	  	  	  	  
4	  
3.2	   Introduction	  ................................................................................................................................................	  65	  3.3	   Methods	  ........................................................................................................................................................	  66	  
3.3.1	   Bacterial	  isolates	  ..................................................................................................................................	  66	  
3.3.2	   Sequence	  analysis	  and	  measure	  of	  the	  associations	  between	  different	  loci	  ...............	  67	  3.4	   Results	  ...........................................................................................................................................................	  67	  
3.4.1	   Prevalence	  and	  Distribution	  of	  Sequence	  Types	  (STs)	  and	  MLST	  Clonal	  Complexes	  
Over	  Time	  ................................................................................................................................................................	  67	  
3.4.2	   Diversity	  and	  Distribution	  of	  fHbp	  ................................................................................................	  68	  
3.4.3	   Diversity	  and	  Distribution	  of	  NHBA	  .............................................................................................	  69	  
3.4.4	   Diversity	  and	  Distribution	  of	  NadA	  ..............................................................................................	  69	  
3.4.5	   Association	  of	  fHbp,	  NadA,	  and	  NHBA	  diversity	  with	  MLST	  Clonal	  Complexes	  .........	  70	  
3.4.6	   Evolution	  of	  cc41/44	  ...........................................................................................................................	  71	  
3.4.7	   Long-­‐term	  Persistence	  of	  Antigen	  Sub/variants	  ....................................................................	  73	  
3.4.8	   Long-­‐term	  Persistence	  of	  Antigen	  Sub/variant	  Combinations	  ........................................	  74	  3.5	   Discussion	  and	  Conclusions	  .................................................................................................................	  75	  
Appendix	  –	  Supplementary	  Material	  ...................................................................................	  81	  
References	  ..........................................................................................................................	  83	  	  	  	  	  	   	  
	  	  	  	  
5	  
Outline	  
My	  PhD	  project,	  described	  in	  this	  thesis,	   is	   focused	  on	  the	  study	  of	  the	  molecular	  variability	  of	  some	  specific	  proteins,	  part	  of	  the	  outer	  membrane	  of	  the	  pathogen	  Neisseria	  
meningitidis,	  and	  described	  as	  protective	  antigens	  and	  important	  virulence	  factors.	  These	  antigens	   have	   been	   employed	   as	   components	   of	   the	   vaccine	   developed	   by	   Novartis	  Vaccines	  against	  N.	  meningitidis	  of	  serogroup	  B,	  and	  their	  variability	  in	  the	  meningococcal	  population	  is	  a	  key	  aspect	  when	  the	  effect	  of	  the	  vaccine	  is	  evaluated.	  The	   PhD	   project	   has	   led	   to	   complete	   three	   major	   studies	   described	   in	   three	   different	  manuscritps,	  of	  which	  two	  have	  been	  published	  and	  the	  third	  is	  in	  preparation.	  The	  thesis	  is	  structured	  in	  three	  main	  chapters,	  each	  of	  them	  dedicated	  to	  the	  three	  studies.	  i. The	   first	   study,	  described	   in	  Chapter	  1,	   is	   specifically	  dedicated	   to	   the	  analysis	  of	   the	  molecular	   conservation	   of	   meningococcal	   antigens	   in	   the	   genomes	   of	   all	   species	  classified	   in	  the	  genus	  Neisseria,	  whose	  complete	  genome	  was	  available	  (Conservation	  
of	   Meningococcal	   Antigens	   in	   the	   Genus	   Neisseria.	   A.	   Muzzi,	   M.	   Mora,	   M.	   Pizza,	   R.	  Rappuoli,	  C.	  Donati.	  2013.	  mBio	  4	  (3)).	  ii. The	   second	   study,	   described	   in	   Chapter	   2,	   focuses	   on	   the	   analysis	   of	   the	   presence,	  distribution	  and	  conservation	  of	  antigens	  in	  a	  panel	  of	  bacterial	  isolates	  obtained	  from	  cases	  of	  the	  disease	  and	  from	  healthy	  individuals,	  and	  collected	  in	  the	  same	  year	  and	  in	  the	  same	  geographical	  area,	  the	  Czech	  Republic	  (Conservation	  of	  fHbp,	  NadA,	  and	  NHBA	  
in	   carrier	   and	   pathogenic	   isolates	   of	   Neisseria	   meningitidis	   collected	   in	   the	   Czech	  
Republic	   in	   1993.	   A.	   Muzzi,	   S.	   Bambini,	   K.	   Jolley,	   M.C.	   Maiden,	   P.	   Kriz,	   R.	   Borrow,	   J.	  Lucidarme,	  et	  al..	  Manuscript	  in	  preparation).	  iii. Finally,	  Chapter	  3	  describes	   the	  molecular	   features	  of	   antigens	   in	  a	  panel	  of	  bacterial	  isolates	  collected	  over	  a	  period	  of	  50	  years,	  and	  representatives	  of	  the	  epidemiological	  history	   of	   meningococcal	   disease	   in	   the	   Netherlands	   (An	   Analysis	   of	   the	   Sequence	  
Variability	   of	   Meningococcal	   fHbp,	   NadA	   and	   NHBA	   over	   a	   50-­‐Year	   Period	   in	   the	  
Netherlands.	  S.	  Bambini,	  J.	  Piet,	  A.	  Muzzi,	  W.	  Keijzers,	  S.	  Comandi,	  L.	  De	  Tora,	  M.	  Pizza,	  et	  
al..	  2013.	  PloS	  one	  8	  (5),	  e65043).	  Furthermore,	  the	  study	  of	  the	  variability	  of	  these	  molecules	  is	  of	  importance	  in	  predicting	  the	  impact	  of	  the	  vaccine	  after	  its	  introduction	  and	  has	  led	  to	  two	  scientific	  papers,	  where	  I	  have	  contributed	  to	  the	  analysis	  of	  the	  level	  of	  conservation	  of	  the	  meningococcal	  antigens	  (references	  [4]	  and	  [5])	  .	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Chapter	  1. Conservation	   of	   Meningococcal	   antigens	   in	   the	  
genus	  Neisseria	  
1.1 Abstract	  
Neisseria	  meningitidis,	  one	  of	  the	  major	  causes	  of	  bacterial	  meningitis	  and	  sepsis,	  is	  a	  member	  of	  the	  Neisseria	  genus,	  which	  includes	  species	  that	  colonize	  the	  mucosae	  of	  many	  animals.	   Three	   meningococcal	   proteins,	   factor-­‐H	   binding	   protein	   (fHbp),	   Neisserial	  Heparin	  Binding	  Antigen	  (NHBA)	  and	  Neisseria	  meningitidis	  adhesin	  A	  (NadA)	  have	  been	  described	  as	  protective	  antigens	  against	  N.	  meningitidis	  of	  serogroup	  B	  and	  they	  have	  been	  employed	   as	   vaccine	   components	   in	   preclinical	   and	   clinical	   studies.	   In	   the	   vaccine	  formulation,	  fHbp	  and	  NHBA	  were	  fused	  to	  GNA2091	  and	  GNA1030	  proteins,	  respectively	  to	   enhance	   protein	   stability	   and	   immunogenicity.	   To	   determine	   the	   possible	   impact	   of	  vaccination	   on	   commensal	   neisseriae,	   we	   determined	   the	   presence,	   distribution	   and	  conservation	  of	  these	  antigens	   in	  the	  available	  genome	  sequences	  of	  the	  Neisseria	  genus,	  finding	   that	   fHbp,	   NHBA	   and	   NadA	  were	   conserved	   only	   in	   species	   colonizing	   humans,	  while	  GNA1030	  and	  GNA2091	  were	  conserved	  in	  many	  human	  and	  non-­‐human	  neisseriae.	  Sequence	   analysis	   showed	   that	   homologous	   recombination	   contributed	   to	   shape	   the	  evolution	   and	   the	   distribution	   of	   both	   NHBA	   and	   fHbp,	   for	   which	   three	  major	   variants	  have	  been	  defined.	  fHbp	  variant	  3	  was	  probably	  the	  ancestral	  form	  of	  meningococcal	  fHbp,	  while	  fHbp	  variant	  1	  was	  introduced	  into	  N.	  meningitidis	  by	  a	  recombination	  event	  from	  N.	  
cinerea.	  fHbp	  variant	  2	  was	  the	  result	  of	  a	  recombination	  event	  inserting	  a	  stretch	  of	  483	  bp	   from	   a	   variant	   1	   on	   a	   variant	   3	   background.	   These	   data	   indicate	   that	   a	   high	   rate	   of	  exchange	   of	   genetic	   materials	   exists	   between	   those	   neisseriae	   that	   colonize	   the	   upper	  respiratory	  tract	  of	  humans.	  	  The	  upper	  respiratory	  tract	  of	  healthy	  individuals	  is	  a	  complex	  ecosystem	  colonized	  by	  many	  bacterial	  species.	  Amongst	  those,	  there	  are	  representatives	  of	  the	  Neisseria	  genus,	  including	  N.	  meningitidis,	  a	  major	  cause	  of	  bacterial	  meningitis	  and	  sepsis.	  Given	  the	  close	  relationship	  between	  commensal	  and	  pathogenic	  species,	  a	  protein-­‐based	  vaccine	  against	  
N.	  meningitidis	  has	   the	  potential	   to	   impact	   the	  other	  commensal	  species	  of	  Neisseria.	  For	  this	   reason,	   we	   have	   studied	   the	   distribution	   and	   evolutionary	   history	   of	   the	   antigen	  components	  of	  a	  recombinant	  vaccine,	  4CMenB	  that	  recently	  received	  approval	  in	  Europe	  under	   the	   commercial	   name	   of	   Bexsero®.	  We	   found	   that	   fHbp,	   NHBA	   and	   NadA	   can	   be	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found	  in	  some	  of	  the	  human	  commensal	  species,	  and	  that	  the	  evolution	  of	  these	  antigens	  has	  been	  essentially	  shaped	  by	  genetic	  exchange	  that	  occurs	  at	  high	  rate	  between	  strains	  of	  neisseriae	  that	  co-­‐colonize	  the	  same	  environment.	  	  
1.2 Introduction	  The	   genus	   Neisseria	   is	   a	   large	   group	   of	   gram-­‐negative	   bacteria.	   Beside	   several	  human	  species	   that	  are	  only	  rarely	  associated	  with	  disease,	   this	  genus	  also	  contains	   two	  major	   human	   pathogens,	   Neisseria	   gonorrhoeae	   and	   Neisseria	   meningitidis.	   The	   latter	  generally	   asymptomatically	   colonize	  humans,	   but	   in	   a	   small	   percentage	  of	   the	   cases	   can	  cause	  systemic	  disease.	  	  The	  taxonomy	  of	  the	  genus	  Neisseria	  based	  on	  sequence	  analysis	  is	  problematic.	   	  Studies	  based	   on	   three	   genes,	   argF,	   recA	   and	   rho	   and	   on	   16S	   rRNA	   have	   shown	   that	   five	  phylogenetic	   groups	   can	  be	   identified,	   each	   including	  more	   than	  one	  named	   species	   [6].	  However,	  probably	  due	  to	   the	  high	   level	  of	  recombination	  between	  these	  organisms,	   the	  species	  within	  these	  groups	  are	  less	  distinct	  than	  what	  is	  normally	  accepted	  in	  molecular	  taxonomy,	  as	  in	  the	  case	  of	  Neisseria	  cinerea	  that	  is	  often	  placed	  within	  the	  N.	  meningitidis	  species.	   Recently	   the	   complete	   phylogeny	   of	   the	   neisseriae	   has	   been	   reconstructed	   by	  ribosomal	   multilocus	   sequence	   typing	   (rMLST)	   and	   an	   accurate	   interpretation	   of	   the	  relationships	   between	   different	   species	   has	   been	   proposed	   [7].	   Moreover,	   many	   of	   the	  genes	  that	  are	  associated	  with	  virulence	  in	  N.	  meningitidis	  are	  present	  also	  in	  commensal	  neisseriae,	   and	   it	   has	   been	   speculated	   that	   the	   latter	   might	   constitute	   a	   reservoir	   of	  virulence	   factors	   for	   the	   pathogenic	   species	   [8].	   In	   some	   cases,	   genetic	   exchange	   is	   less	  frequent	   due	   to	   the	   different	   ecology,	   as	   for	   instance	   between	   N.	   meningitidis	   and	   N.	  
gonorrhoeae	  [9].	  	  Currently,	  capsular	  polysaccharide-­‐based	  vaccines	  for	  the	  A,	  C,	  Y	  and	  W-­‐135	  serogroups	  of	  
N.	   meningitidis	   are	   available,	   while	   the	   development	   of	   a	   polysaccharide	   vaccine	   for	  serogroup	  B	  was	  not	  possible	  due	  to	  the	  similarity	  to	  a	  human	  carbohydrate	  thus	  inducing	  a	   weak	   immunoresponse	   and	   with	   the	   risk	   of	   autoimmunity.	   	   For	   this	   reason,	   a	  multicomponent	  protein	  based	  vaccine	  known	  as	  4CMenB	  has	  been	  proposed	  [1].	  4CMenB	  was	   recently	   approved	   in	   Europe	   under	   the	   commercial	   name	   of	   Bexsero®.	   4CMenB	  includes	  three	  main	  antigens:	  the	  factor	  H	  binding	  protein	  (fHbp),	  the	  Neisserial	  Heparin-­‐Binding	  Antigen	  (NHBA)	  and	  the	  Neisseria	  meningitidis	  adhesin	  A	  (NadA).	  Two	  additional	  proteins,	   GNA2091	   and	   GNA1030,	   were	   incorporated	   into	   fusion	   proteins	   with	   fHbp	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(GNA2091-­‐fHbp)	  and	  NHBA	  (NHBA–GNA1030),	  respectively,	  to	  enhance	  protein	  stability	  and	  increase	  immunogenicity	  [1].	  	  NadA	  was	  included	  as	  a	  single	  protein	  antigen.	  fHbp	   is	   a	   surface-­‐exposed	   lipoprotein	   that	  binds	   factor	  H	   (fH),	   a	   key	   inhibitor	  of	  the	  complement	  alternative	  pathway,	   leading	   to	  evasion	  of	  killing	  by	   the	   innate	   immune	  system	  [10].	  The	  expression	  of	  fHbp	  by	  N.	  meningitidis	  strains	  is	  important	  for	  survival	  in	  human	  blood	  and	  human	  serum	  [11].	  With	  very	  few	  exceptions	  [12,	  13],	  the	  gene	  coding	  for	  fHbp	  is	  present	  in	  N.	  meningitidis	  of	  serogroup	  B	  strains	  in	  three	  major	  genetic	  variants	  (variant	   1,	   2	   and	   3)	   and	   in	  N.	  gonorrhoeae	   in	   one	   of	   the	   three	   variants	   [14].	   The	   three	  variants	   are	   not	   fully	   cross-­‐protective	   [3,	   15],	  with	   variant	   1	   that	   does	   not	   show	   cross-­‐protection	  activity	  versus	  variants	  2	  and	  3	  and	  vice	  versa.	  	  NHBA,	   predicted	   to	   be	   a	   surface	   exposed	   lipoprotein,	   was	   selected	   as	   vaccine	  candidate	  with	  the	  name	  of	  GNA2132	  (i.e.	  Genome-­‐derived	  Neisseria	  Antigen	  2132),	   in	  a	  genome-­‐wide	  discovery	  program	  of	  vaccine	  targets	  [16].	  GNA2132	  was	  shown	  to	  be	  able	  to	  induce	  bactericidal	  antibodies	  in	  humans,	  and	  to	  bind	  heparin,	  improving	  the	  survival	  of	  the	   meningococcus	   in	   human	   serum.	   For	   this	   reason,	   it	   was	   later	   renamed	   NHBA	  (Neisserial	   Heparin	   Binding	   Antigen)	   [17].	   NHBA	   is	   ubiquitous	   in	   meningococci	   of	  serogroup	  B	  [4,	  13,	  18].	  	  NadA	   is	   a	   meningococcal	   surface-­‐anchored	   protein	   from	   the	   family	   of	   trimeric	  autotransporters	   (TAs)	   [19]	  which	  are	  understood	   to	  export	   themselves	   to	   the	  bacterial	  surface	   with	   no	   external	   energy	   source	   or	   auxiliary	   proteins.	   Recent	   data	   suggest	   that	  other	  proteins	  might	  be	   involved	   in	   their	   secretion,	   and	   further	   investigation	   is	  ongoing	  [20].	  The	  gene	  coding	  for	  NadA	  is	  present	  in	  three	  out	  of	  the	  four	  hypervirulent	  lineages	  of	  
N.	  meningitidis	  of	  serogroup	  B,	  and	  is	  absent	  in	  the	  pathogenic	  N.	  gonorrhoeae	  and	  in	  the	  commensals	  N.	  lactamica	  and	  N.	  cinerea	  [21,	  22].	  	  Although	  their	  functional	  activity	  is	  not	  known,	   GNA1030	   and	   GNA2091	   were	   shown	   to	   induce	   protective	   immunity	   in	   serum	  bactericidal	  essays	  in	  mice	  [1].	  	  The	  fHbp,	  nhba	  and	  nadA	  genes	  are	  also	  known	  to	  be	  present	  in	  invasive	  strains	  of	  
N.	  meningitidis	  of	  other	  serogroups	   like	  serogroup	  C	  [4,	  23],	  X	   [24],	  Y	   [4,	  23]	  and	  W-­‐135	  [18]	  and	  in	  particular	  fHbp	  was	  investigated	  in	  Africa	  in	  epidemic	  strains	  of	  serogroup	  A,	  X	  and	  W-­‐135	  [25,	  26].	  	  These	  studies	  demonstrated	  the	  higher	  level	  of	  clonality	  of	  the	  non-­‐B	  isolates,	   with	   the	   exception	   of	   serogroup	   C,	   not	   only	   in	   terms	   of	   genetic	   differences	   of	  strains	  but	  also	  in	  terms	  of	  molecular	  variability	  of	  these	  important	  antigens.	  To	  evaluate	  whether	  these	  antigens	  are	  present	  only	  in	  pathogenic	  neisseriae	  or	  are	  also	   present	   in	   other	   species	   belonging	   to	   this	   genus,	   we	   analysed	   their	   presence,	  distribution	  and	  conservation	  in	  the	  complete	  and	  draft	  genome	  sequences	  of	  80	  strains	  of	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pathogenic	  and	  commensal	  neisseriae,	   that	  were	  available	   in	  public	  databases.	   	  We	  used	  the	   Single	   Nucleotide	   Polymorphisms	   (SNPs)	   retrieved	   from	   the	   alignments	   of	   these	  sequences	   against	   the	   genome	   of	   N.	   meningitidis	   MC58	   to	   resolve	   the	   relationships	  between	   the	   species	   closely	   related	   to	   N.	   meningitidis	   that	   could	   not	   be	   clearly	  distinguished	  using	  16S	  rRNA.	  By	  comparing	  the	  phylogenetic	  relationships	  between	  the	  genes	   to	   the	  whole-­‐genome	   phylogenetic	   tree	   and	   by	   analyzing	   the	   conservation	   of	   the	  genomic	   loci	   where	   the	   genes	   were	   inserted,	   we	   demonstrated	   the	   effect	   of	   the	   inter-­‐species	  transfer	  of	  genetic	  material	  in	  their	  evolution.	  	  
1.3 Methods	  
1.3.1 Phylogenetic	  analysis	  of	  the	  Neisseria	  genus.	  	  1080	   aligned	   16S	   rRNA	   sequences	   of	   the	   species	   belonging	   to	   the	  Neisseria	   genus	  were	  downloaded	   (January	   2012)	   from	   the	   Ribosomal	   Database	   Project	   web	   site	  (http://rdp.cme.msu.edu/index.jsp).	   The	   sequences	   were	   pruned	   by	   keeping	   only	  sequences	   that	  were	  more	   than	   1%	  divergent,	   obtaining	   a	   sample	   of	   48	   sequences	   that	  were	   representative	   of	   the	   diversity	   of	   the	   genus.	   From	   these,	   a	   Maximum	   Likelihood	  phylogenetic	   tree	   was	   computed	   based	   on	   the	   Tamura	   3	   parameter	   model	   [27].	   Site	  variability	   was	   modelled	   with	   a	   Gamma	   distribution	   (5	   categories,	   G=0.1273)	   plus	  invariants	   (I=66.74%	  of	   the	  sites).	   	  The	  values	  of	   the	  parameters	  were	  optimized	  on	   the	  data.	  For	  each	  branch,	  bootstrap	  consensus	  was	  inferred	  from	  500	  replicates.	  The	  analysis	  was	  conducted	  using	  Mega5	  [28].	  Phylogenetic	  networks	  were	  computed	  using	  SplitsTree	  [29,	  30].	  
1.3.2 Estimate	  of	  the	  recombination	  and	  mutation	  rate.	  	  	  The	   population	   scaled	   recombination	   rate	   r	   and	   the	   population	   scaled	   mutation	   rate	   q	  were	   estimated	   with	   the	   LDHat	   method	   [31]	   and	   with	   the	   Watterson	   estimator	   [32],	  respectively,	  using	  the	  software	  package	  RDP3	  [33].	  
1.3.3 Genome	  sequences.	  	  The	  18	  complete	  and	  49	  draft	  genome	  sequences	  of	  67	  isolates	  belonging	  to	  the	  Neisseria	  genus	  were	  retrieved	  from	  GenBank	  (December	  2011).	  To	  improve	  the	  representativeness	  of	   the	   dataset,	  we	   downloaded	   (December	   2012)	   18	   additional	   genome	   sequences	   of	  N.	  
cinerea	   (5	   strains),	   N.	   polysaccharea	   (7	   strains),	   and	   N.	   lactamica	   (6	   strains)	   from	   the	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Neisseria	   PubMLST	   database	   (http://pubmlst.org/perl/bigsdb/bigsdb.pl?db=	  pubmlst_neisseria_isolates).	   	   Of	   these,	   5	   (1	   N.	   cinerea,	   3	   N.	   lactamica	   and	   1	   N.	  
polysaccharea)	  were	  re-­‐sequencing	  of	  strains	  already	  present	  in	  the	  GenBank	  dataset	  that	  we	  included	  to	  correct	  potential	  sequencing	  error	  in	  the	  draft	  genomes.	  The	  draft	  genomes	  were	  composed	  by	  between	  23	  and	  574	  contigs.	  A	  complete	  list	  of	  the	  isolates	  is	  available	  in	  Table	  S1	  in	  the	  supplemental	  material.	  As	  indicated	  in	  Table	  S1,	  of	  the	  27	  strains	  of	  N.	  
meningitidis,	  2	  strains	  were	  characterized	  as	  strains	  of	  serogroup	  A,	  17	  of	  serogroup	  B,	  5	  of	  serogroup	  C,	  1	  of	  serogroup	  X,	  1	  of	  serogroup	  Y	  and	  one	  strain	  was	  not	  typeable	  because	  capsule	  null	  locus.	  
1.3.4 Genome	  alignments	  and	  phylogenetic	  analysis	  of	  the	  sequenced	  strains.	  Pair-­‐wise	   genome	   alignments	   of	   all	   sequences	   against	   the	   genome	   sequence	   of	   N.	  
meningitidis	   MC58	   were	   computed	   using	   Nucmer	   [34].	   From	   these,	   223369	   Single	  Nucleotide	   Polymorphysms	   (SNPs)	   were	   identified	   in	   the	   core	   genome	   and	   the	  corresponding	  alleles	   in	   all	   strains	  were	  extracted.	  Phylogenetic	   analysis	  was	   conducted	  using	  the	  Neighbor-­‐Joining	  method	  [35].	  Evolutionary	  distances	  were	  calculated	  using	  the	  Maximum	  Composite	   Likelihood	  method	   [36].	   The	   analysis	  was	   conducted	   using	  Mega5	  [28].	  Phylogenetic	  networks	  were	  calculated	  using	  SplitsTree4	  [29,	  30].	  
1.3.5 Genome	  annotation.	  Annotation	  transfer	  for	  draft	  genomes	  was	  performed	  using	  RATT	  [37].	  In	  particular,	   for	  
N.	   polysaccharea	   ATCC	   43768	   (accession	   number	   ADBE00000000)	   we	   used	   the	  annotation	  of	  N.	  gonorrhoeae	  FA	  1090	  (accession	  number	  AE004969)	  as	  template.	  For	  N.	  
cinerea	   ATCC	   14685	   (accession	   number	   ACDY00000000)	   we	   used	   the	   annotation	   of	  N.	  
meningitidis	  MC58	  (accession	  number	  AE02098)	  as	  template.	  
1.3.6 Criteria	  for	  genes	  presence/absence.	  The	   presence	   of	   the	   fHbp,	   nhba	   and	   nadA	   coding	   genes	   was	   verified	   by	   nucleotide	  alignments	  against	  predicted	  coding	  genes,	  and	  finally	  checked	  with	  TFASTY	  [38]	  to	  find	  possible	  pseudogenes	  or	  coding	  sequences	  not	  predicted	  in	  the	  genome	  annotation.	  fHbp	  query	  sequences	  were	  representative	  of	  the	  three	  major	  molecular	  variants	  [3].	  For	  NHBA,	  nucleotide	  sequences	  coding	  for	  peptides	  from	  1	  to	  21,	  representative	  of	  the	  diversity	  of	  the	  molecule	  in	  N.	  meningitidis	  [4,	  39],	  were	  used	  as	  query	  sequences.	  	  For	  NadA,	  the	  query	  sequences	  were	  representative	  of	   the	   five	  major	  protein	   forms	  [39].	  To	   identify	  possible	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distant	   homologues,	   the	   BLAST	   E-­‐score	   cut-­‐off	   was	   set	   to	   10^-­‐5,	   and	   the	   sequence	  alignments	  were	  then	  manually	  checked	  to	  identify	  true	  homologues.	  Gene	  loci	  were	  also	  inspected	  by	  considering	  the	  whole	  genome	  alignment	  performed	  by	  Mauve	  [40]	  and	  the	  level	  of	  conservation	  of	  each	  Locally	  Collinear	  Block	  (LCB)	  containing	  the	  genes.	  	  	  
1.3.7 Phylogenetic	  analysis	  of	  fHbp,	  nhba	  and	  nadA.	  	  Maximum	  Likelihood	  phylogenetic	  trees	  were	  built	  for	  each	  antigen	  based	  on	  the	  Kimura	  2	   parameters	   model	   with	   Gamma	   correction.	   Branch	   stability	   was	   tested	   by	   bootstrap	  consensus	  of	  500	  replicates.	  The	  analysis	  was	  conducted	  using	  Mega5	  [28].	  Phylogenetic	  networks	  were	  built	  using	  SplitTree4	   [29].	  Phylogenetic	  distances	  were	   computed	  using	  the	   Kimura	   2	   parameters	   model	   with	   Gamma	   correction,	   using	   the	   values	   of	   the	  parameters	  obtained	  by	  Mega5.	  
1.3.8 Identification	  of	  recombination	  events.	  	  To	   test	   the	   presence	   of	   recombination,	   a	  multiple	   alignment	   of	   each	   locus	  was	   built	   by	  extending	  the	  fHbp,	  nhba	  and	  nadA	   loci	  by	  10	  kbps	  upstream	  and	  downstream	  (or	  to	  the	  edge	   of	   the	   contig	   in	   the	   unfinished	   genomes	   if	   this	   was	   closer	   than	   10kb).	   The	   draft	  genomes	  that	  were	  fragmented	  in	  the	  neighborhood	  of	  the	  gene	  locus	  were	  not	  included	  in	  the	   alignment.	   Recombination	   events	   were	   inferred	   with	   RDP3	   [33]	   using	   the	   RDP,	  Geneconv,	  MaxChi,	  Bootscan,	  Chimaera,	  3Seq,	  and	  Siscan	  methods.	  	  
1.4 Results	  
1.4.1 Phylogeny	  of	  the	  genus	  Neisseria.	  A	  phylogenetic	  analysis	  of	   the	  Neisseria	  genus	  based	  on	  48	  16S	  rRNA	  sequences	  that	  are	  representative	  of	  the	  diversity	  of	  the	  genus	  resulted	  in	  a	  tree	  with	  generally	  low	  values	  of	  bootstrap	  support	  (Figure	  1.1).	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  However,	  we	  could	  distinguish	  one	  branch	  containing	  the	  two	  species	  that	  are	  pathogenic	  in	  humans,	   i.e.	  N.	  meningitidis	  and	  N.	  gonorrhoeae,	   together	  with	  the	  human	  commensals	  
N.	  cinerea,	  and	  N.	  polysaccharea.	  Within	   this	  branch,	  different	  strains	  of	   the	  same	  named	  species	  did	  not	  form	  monophyletic	  groups.	  This	  inability	  to	  resolve	  the	  relations	  between	  the	  different	  species	  was	  due	  both	  to	  the	  weak	  phylogenetic	  signal	  in	  16S	  rRNA	  sequences	  and	  to	  the	  high	  level	  of	  homologous	  recombination	  within	  and	  between	  these	  species,	  that	  can	  be	  visualized	  by	  constructing	  a	  phylogenetic	  network	  (Figure	  1.2),	  where	  it	  is	  almost	  impossible	  to	  clearly	  distinguish	  branches	  corresponding	  to	  named	  species.	  We	  estimated	  the	  relative	  contributions	  of	  recombination	  and	  mutation	  to	  the	  diversification	  of	  this	  set	  
	  
	   Figure	   1.1	   Maximum	   Likelihood	   phylogenetic	   tree	   obtained	   from	   16S	   rRNA	   sequences.	  The	  bootstrap	  values	  are	  reported.	  In	  this	  tree,	  strains	  of	  the	  same	  named	  species	  do	  not	  form	   monophyletic	   branches.	   A	   branch	   containing	   sequences	   from	   N.	   meningitidis,	   N.	  
gonorrhoeae,	  N.	  polysaccharea	  and	  N.	  cinerea	  can	  be	  identified.	  	  Coloured	  circles	  and	  labels	  indicate	  species	   for	  which	  a	  whole	  genome	  sequence	  was	  available.	   In	  particular,	  purple	  indicates	   those	   sequences	   where	   none	   of	   the	   three	   antigens	   was	   conserved,	   while	   the	  other	   sequences	  are	   coloured	   according	   to	   the	  species.	   (T)	   indicates	   the	  Type	   strain	   for	  the	  species.	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of	  sequences	  by	  measuring	  the	  population	  scaled	  recombination	  rate	  r	  and	  the	  mutation	  rate	  q.	  We	  obtained	  r=0.042	  and	  q=0.015,	  yielding	  a	  value	  for	  the	  ratio	  r/q=2.8.	  This	  value,	  computed	   across	   the	   different	   neisseriae	   species,	   is	   only	   marginally	   smaller	   than	   the	  estimates	  of	  the	  r/q	  ratio	  (r/q=3.1)	  obtained	  from	  strains	  belonging	  only	  to	  N.	  meningitidis	  using	  the	  sequences	  of	  fragments	  of	  7	  housekeeping	  genes	  [41,	  42].	  The	  fact	  that	  the	  value	  obtained	  by	  analysing	  exclusively	  sequences	  of	  N.	  meningitidis	  is	  comparable	  to	  the	  value	  obtained	   by	   analysing	   sequences	   of	   isolates	   belonging	   to	   different	   species	   of	   neisseriae	  suggests	   that	   homologous	   recombination	   plays	   a	   fundamental	   role	   not	   only	   in	   the	  diversification	  of	   lineages	  within	   the	  N.	  meningitidis	   species	   [42],	   but	   also	   in	  driving	   the	  speciation	  process	  within	  the	  Neisseria	  genus	  [43].	  	  In	  Figure	  1.1	  we	  also	   indicated	   the	  species	   for	  which	  at	   least	  one	  genome	  sequence	  was	  available	   (see	   Table	   1.1).	   Although	   the	   sample	   was	   biased	   towards	   those	   species	   that	  colonize	  humans,	   the	   available	   genomes	  allowed	   the	   sampling	  of	   all	   the	  branches	  of	   the	  tree.	   On	   these	   genomes,	   we	   verified	   the	   conservation	   of	   the	   three	   major	   antigens	  contained	  in	  the	  4CMenB	  vaccine,	  namely	  fHbp,	  nhba	  and	  nadA,	  and	  highlighted	  (in	  purple	  in	  Figure	  1.1)	   those	   sequences	  where	  none	  of	   the	   three	  antigens	  was	  present,	  while	   the	  
	  Figure	   1.2	   Phylogenetic	   network	   obtained	   using	   the	   16S	   rRNA	   sequences	   of	   48	   isolates	  representative	   of	   the	   diversity	   of	   the	   Neisseria	   genus.	   The	   non	   tree-­‐like	   structure	   of	   the	  network	   is	   probably	   the	   consequence	   of	   widespread	   recombination	   within	   the	   Neisseria	  genus.	  Coloured	  labels	  indicate	  the	  different	  species	  of	  Neisseria.	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other	  sequences	  are	  coloured	  according	  to	  the	  species.	  With	  the	  exception	  of	  N.	  flavescens,	  all	  the	  genomes	  where	  at	  least	  one	  antigen	  was	  present	  were	  concentrated	  in	  one	  branch	  of	   the	   tree,	   including	   N.	  meningitidis,	   N.	   gonorrhoeae,	   N.	   polysaccharea,	   N.	   lactamica,	   N.	  
cinerea,	  N.	  flava,	  M.	  cerebrosus,	  N.	  macacae,	  and	  three	  unidentified	  neisseriae.	   	  To	  resolve	  the	   ambiguities	   of	   the	   taxonomy	   of	   this	   branch,	   we	   performed	   a	   genome	   wide	  phylogenetic	  analysis	  on	  the	  available	  complete	  and	  draft	  genome	  sequences	  (Figure	  1.3).	  This	  analysis	  included	  all	  the	  sequences	  where	  at	  least	  one	  of	  the	  three	  genes,	  fHbp,	  nhba	  or	  nadA	   was	   found.	  N.	   flavescens	   was	   excluded	   from	   this	   analysis	   because	   the	   available	  genome	  was	   too	   divergent	   from	   the	   other	   sequences	   to	   allow	   a	   reliable	   alignment.	   The	  different	   species	   were	   well	   separated	   with	   no	   ambiguities,	   and	   all	   the	   branches	   were	  supported	  by	  high	  values	  of	  bootstrap	  (for	  clarity,	  the	  branches	  containing	  more	  than	  one	  strain	  of	   the	   same	   species	  were	   grouped	   in	   grey	   areas;	   the	   complete	   tree	   is	   reported	   in	  
	  Figure	  1.3	  Neighbour	   Joining	  phylogenetic	   tree	  with	  evolutionary	  distances	   calculated	  using	  the	  Maximum	   Composite	   Likelihood	   method	   obtained	   from	   the	   SNPs	   in	   the	   portion	   of	   the	  multiple	  alignment	  shared	  by	  all	  strains.	  The	  alignment	  includes	  51	  strains	  of	  N.	  meningitidis,	  
N.	  gonorrhoeae,	  N.	  polysaccharea	  and	  N.	  lactamica.	  For	  clarity,	   the	  branches	   including	   the	  N.	  
meningitidis,	  N.	  gonorrhoeae,	  and	  N.	  lactamica	  strains	  are	  grouped	  in	  distinct	  grey	  areas.	  The	  presence	  of	  fHbp,	  nhba	  and	  nadA	   is	  indicated.	  For	   fHbp	  the	  colours	  indicate	  the	  major	  allelic	  variants.	  In	  the	  case	  of	  N.	  meningitidis,	  fHbp	   is	  present	  in	  all	  strains	  in	  one	  of	  the	  three	  major	  variants.	  nadA	   is	  present	  in	  N.	  meningitidis	   in	  7	  out	  of	  27	  strains	  with	  the	  correct	  translation	  frame.	  nhba	  is	  ubiquitous	  with	  the	  exception	  of	  N.	  cinerea.	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Figure	  1.4).	  Amongst	  these	  species,	  N.	  gonorrhoeae	  was	  the	  one	  most	  closely	  related	  to	  N.	  
meningitidis,	  and	  showing	  the	  smallest	  variability	  within	  the	  sequenced	  strains,	  suggesting	  that	  this	  species	  differentiated	  recently	  from	  an	  ancestor	  of	  contemporary	  N.	  meningitidis.	  In	   this	   reconstruction,	   the	   sequenced	   strains	   of	  N.	   cinerea	   were	   distantly	   related	   to	  N.	  
polysaccharea,	  and	  clearly	  distinct	  from	  N.	  meningitidis,	  confirming	  recent	  results	  based	  on	  the	  analysis	  of	  the	  concatenated	  sequences	  of	  core	  genes	  [8].	  
	  
Table	   1.1	   Summary	   of	   the	   fHbp,	  nhba,	   and	  nadA	   genes	   level	   of	   conservation	   in	   80	   neisserial	  complete	   and	   draft	   genomes.	   The	  %	   of	   identity	   is	   calculated	  with	   respect	   to	   the	   form	   of	   the	  same	  proteins	   that	   are	   included	   in	   the	  4CMenB	  vaccine	   [1].	   Beside	   intact	   genes,	  we	   included	  frameshifted	  (FS)	  or	  interrupted	  by	  a	  contig	  edge	   fHbp	  and	  nhba	  genes	   in	  N.	  polysaccharea,	  N.	  
lactamica,	  N.	  flavescens	  and	  N.	  gonorrhoeae,	  a	  200aa	   fragment	  of	  NadA	   in	  N.	  cinerea	   close	   to	  a	  contig	  edge,	  two	  frameshifted	  NadA	  genes	  and	  one	  interrupted	  by	  IS4	  in	  N.	  meningitidis.	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1.4.2 Conservation	  of	  fHbp	  Amongst	  the	  sequenced	  genomes	  of	   the	  Neisseria	  genus,	   the	  gene	  encoding	  for	   fHbp	  was	  present	  only	  in	  species	  closely	  related	  to	  N.	  meningitidis,	  i.e.	  N.	  gonorrhoeae,	  N.	  cinerea	  and	  
N.	  polysaccharea,	  while	  it	  was	  absent,	  amongst	  others,	  from	  all	  N.	  lactamica	  strains	  (Table	  
	  Figure	  1.4	  Neighbour	  Joining	  phylogenetic	  tree	  obtained	   from	  the	  SNPs	  in	   the	  portion	  of	  the	  multiple	  alignment	  shared	  by	  all	  strains.	  The	  alignment	  includes	  64	  strains	  of	  N.	  meningitidis,	  
N.	   gonorrhoeae,	  N.	   polysaccharea	   and	   N.	   lactamica	   of	   which	   6	   have	   a	   duplicated	   sequence	  retrieved	  from	  multiple	  genome	  sequencing	  projects.	  The	  (§)	  symbol	  indicates	  sequences	  that	  were	  downloaded	  from	  the	  BigsDB	  database,	  otherwise	  from	  GenBank.	  The	  presence	  of	  fHbp,	  
nhba	  and	  nadA	  is	  indicated.	  For	  fHbp	  the	  colours	  indicate	  the	  major	  allelic	  variants,	  asterisks	  (*)	  indicate	  genes	  that	  were	  frameshifted,	  at	  the	  border	  of	  a	  contig	  or	  interrupted	  by	  the	  an	  IS.	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1.1).	   Interestingly,	   in	   6/7	   of	   the	   available	   strains	   of	   N.	   polysaccharea,	   the	   gene	   was	  frameshifted	  in	  different	  positions,	  suggesting	  that	  this	  gene	  does	  not	  confer	  a	  significant	  selective	  advantage	   in	   this	   species.	   In	  all	   strains	  of	  N.	  gonorrhoeae	   and	  N.	  polysaccharea,	  the	   fHbp	   gene	  could	  be	  attributed	   to	   the	  variant	  3,	  while	   in	  N.	  cinerea	  the	  gene	  could	  be	  classified	   as	   a	   variant	   1	   (Figure	   1.5).	   The	   major	   differences	   between	   gonococcal	   and	  meningococcal	  fHbp	  were	  concentrated	  in	  the	  N-­‐term	  portion	  of	  the	  molecule	  (Figure	  1.6)	  where	   the	   insertion	   of	   a	   single	   base	   (G)	   at	   position	   40	   causes	   a	   frame-­‐shift	   in	   all	  gonococcal	  strains,	  which	  results	  in	  the	  loss	  of	  the	  lipo-­‐box	  motif.	  	  
	  Figure	  1.5	  Maximum	  Likelihood	   phylogenetic	   tree	   of	   the	   fHbp	   gene.	   The	   tree	  was	   obtained	  using	   the	  Kimura	  2	  parameters	  model	  with	  Gamma	  correction.	  The	  average	  gene	  variability	  was	  Pi	  =	  0.131	  (s.e.	  0.011).	  Also	  including	  sequences	  from	  other	  species,	  the	  tree	  showed	  the	  typical	   structuring	   in	   three	   branches,	   variant	   1,	   2	   and	   3	   as	   already	   described	   in	   N.	  
meningitidis.	   In	   particular	  N.	  gonorrhoeae	   strains	  harboured	   variant	   3	   like	   genes,	   as	  well	   as	  the	  two	  N.	  polysaccharea	  strains.	  N.	  cinerea	  harboured	  a	  fHbp	  variant	  1	  very	  similar	  to	  the	  N.	  
meningitidis	  molecules.	  Coloured	  circles	  and	  labels	  indicate	  the	  different	  species	  of	  Neisseria.	  The	   (§)	   symbol	   indicates	   sequences	   that	   were	   downloaded	   from	   the	   BigsDB	   database,	  otherwise	  from	  GenBank.	  The	  (#)	  symbol	  indicates	  genes	  that	  were	  at	  the	  border	  of	  a	  contig.	  Asterisks	  (*)	  indicate	  genes	  that	  were	  frameshifted.	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When	   fHbp	   is	   present,	   the	   entire	   locus	   harbouring	   the	   gene	   was	   conserved	   and	   it	   was	  located	  between	  the	  homologues	  of	  NMB1869	  and	  NMB1871	  (named	  according	  to	  strain	  MC58,	   Figure	   1.7A	   and	  B).	   As	   previously	   reported	   [44]	   	   the	   locus	  was	   highly	   conserved	  also	   in	  N.	  lactamica	  where	  the	   fHbp	  gene	  was	  always	  substituted	  by	  a	  gene	  annotated	  as	  
	  Figure	   1.6	   Multiple	   alignment	   of	   the	   N-­‐term	   portion	   of	   the	   fHbp	   gene,	   where	   the	   major	  differences	   between	   gonococcal	   and	   meningococcal	   fHbp	   were	   concentrated.	   In	   both	  gonococcal	  and	  meningococcal	  strains	  the	  start	  codon	  was	  present	   in	   the	  same	  position,	  but	  the	  insertion	  of	  a	  single	  base	  (G)	  at	  position	  40	  causes	  a	  frame-­‐shift	  in	  all	  gonococcal	  strains,	  which	   results	   in	   the	   loss	   of	   the	   lipo-­‐box	  motif.	   The	   correct	   frame	  was	   re-­‐established	  with	   a	  further	  eight-­‐base	   insertion	  after	  position	  70	  [3].	   In	  4	  cases	  (strains	  DGI2,	  MS11,	  PID18	  and	  PID1)	  the	  insertion	  was	  of	  nine	  bases,	  and	  the	  correct	  frame	  of	  translation	  was	  not	  restored.	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“putative	   opacity	   protein”	   on	   the	   opposite	   strand	   (Figure	   1.7A).	   	   Finally,	   in	  most	   of	   the	  strains	  lacking	  a	  clear	  homologue	  of	  the	  fHbp,	  we	  observed	  the	  presence	  of	  weak	  similarity	  hits	   (between	   30%	   to	   40%	   similarity)	   against	   proteins	   that	   were	   mainly	   annotated	   as	  “fHbp	   proteins”,	   or	   weaker	   hits	   (approximately	   20%	   similarity)	   against	   proteins	  annotated	  as	  “hypothetical	  lipoproteins”.	  Despite	  a	  conserved	  lipoprotein	  motif,	  these	  hits,	  located	  in	  a	  different	  genomic	  region,	  could	  not	  be	  aligned	  to	  the	  factor	  H	  binding	  proteins	  of	  N.	  meningitidis.	  	  We	   then	  analysed	  a	  multiple	  alignment	  of	   a	   region	  of	  10kbp	   including	   the	   fHbp	   gene,	   to	  identify	  homologous	  recombination	  events	   that	  contributed	   to	   its	  evolution	  (Figure	  1.8).	  For	   clarity,	   a	   single	   representative	   for	   each	   group	   of	   strains	   with	   a	   similar	   pattern	   of	  recombination	   is	   shown,	   i.e.	   FA	  1090	   for	   gonococcus,	  CCUG27178A	   for	  N.	  cinerea,	  MC58	  and	  M04-­‐240196	  for	  meningococcus	  fHbp	  variant	  1,	  8013	  for	  variant	  2	  and	  M01-­‐240355	  for	   variant	   3.	   A	   complete	   diagram	   including	   all	   the	   events	   on	   a	   selection	   of	   22	  representative	  sequences	  is	  shown	  in	  Figure	  1.9.	  Two	  major	  events	  could	  be	  identified	  in	  Figure	  1.8:	  i)	  fHbp	  variant	  1	  was	  imported	  into	  N.	  meningitides	  from	  N.	  cinerea	  in	  an	  event	  
	  Figure	  1.7	  (A)	  Alignment	  of	  the	  fHbp	  locus	  in	  N.	  lactamica	  strain	  020-­‐06,	  N.	  meningitidis	  strain	  M01-­‐240355,	  N.	  gonorrhoeae	  strain	   FA	   1090	   and	  N.	  polysaccharea	   strain	   ATCC	   43768.	   The	  
fHbp	  gene	   is	   indicated	  in	  green.	   In	  three	  cases	  (N.	  meningitidis	  M01-­‐240149,	  WUE_2594	  and	  Z2491)	  the	  intergenic	  region	  between	  the	  homologues	  of	  NMB1869	  and	  the	  fHbp	  showed	  the	  insertion	  of	  a	  highly	  conserved,	  AT-­‐rich	  DNA	  fragment	  of	  186-­‐187	  bp	  [2]	  corresponding	  to	  the	  direct	   repeat	   portion	   of	   the	   IS1106	   (GenBank:	   Z11857.1)	   and	   responsible	   of	   the	   fHbp	  promoter	   displacement	   from	   its	   start	   codon.	   The	   entire	   locus	   is	   conserved	   in	   the	   reverse	  strand	   in	  all	   strains	  of	  N.	  gonorrhoeae	  and	  N.	  polysaccharea,	  where	   fHbp	   is	  always	  variant	  3,	  while	  in	  both	  strains	  of	  N.	  polysaccharea	  the	  homologue	  of	  the	  fHbp	  gene	  is	  frameshifted.	  The	  
fHbp	  gene	  is	  absent	  in	  all	  strains	  of	  N.	  lactamica,	  where	  it	  is	  substituted	  by	  a	  protein	  annotated	  as	   “putative	   opacity	   protein”	   in	   the	   opposite	   strand	   (in	   yellow).	   (B)	   fHbp	   locus	   in	   N.	  
meningitidis	  MC58	  and	  in	  N.	  cinerea	  	  strain	  ATCC	  1468.	  In	  both	  cases	  the	  fHbp	  gene	  is	  variant	  1.	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spanning	  also	  the	  cbbA	  gene,	  that	  is	  located	  upstream	  of	  fHbp;	  ii)	  fHbp	  variant	  2	  originated	  by	  the	  substitution	  of	  a	  portion	  of	  a	  variant	  3	  by	  the	  homologous	  sequence	  from	  a	  variant	  1	  strain.	  The	  latter	  event	  could	  be	  seen	  clearly	  from	  a	  multiple	  alignment	  of	  the	  variant	  2	  and	  variant	  3	  fHbp	  sequences,	  shown	  in	  Figure	  1.10.	  The	  putative	  donor	  was	  identified	  by	  RDP	   analysis	   as	  N.	   cinerea	   strain	   CCUG27178A,	   but,	   given	   the	   high	   similarity	   of	   the	  N.	  
cinerea	   gene	   with	   the	  N.	  meningitidis	   variant	   1	   genes,	   we	   could	   not	   exclude	   that	   other	  undetected	   intermediate	   steps	   occurred.	   This	   complex	   pattern	   of	   recombination	   was	  probably	  the	  cause	  leading	  to	  the	  observed	  modular	  organization	  of	  the	  fHbp	  gene	  [45].	  	  	  	   	  
	  Figure	  1.8	   Schema	  of	   the	  recombination	  events	  spanning	   the	   fHbp	  gene.	  The	  position	  of	   the	  genes	  in	  the	  MC58	  sequence	  are	  shown.	  The	  black	  box	  indicates	  the	  position	  of	  the	  fHbp	  gene.	  A	   single	   representative	   for	   each	   group	   of	   sequences	   showing	   a	   similar	   pattern	   of	  recombination	   events	   is	   reported.	   Each	   horizontal	   bar	   represents	   the	   locus	   in	   the	   genome	  indicated	   on	   the	   left.	   Light	   boxes	   drawn	   within	   each	   bar	   represent	   putative	   segments	  transferred	  by	  recombination.	  The	  imported	  fragments	  are	  represented	  by	  specific	  boxes	  that	  are	  drawn	  below	  each	  bar.	  The	  name	  of	  a	  putative	  donor	  strain	  is	  indicated	  on	  the	  right.	  The	  
fHbp	   variant	   1	   (strain	   MC58)	   appears	   to	   have	   been	   imported	   into	   N.	   meningitidis	   by	   a	  recombination	  event	  including	  also	  the	  upstream	  cbbA	  gene,	  while	  the	  fHbp	  variant	  2	  was	  the	  result	   of	   the	   recombination	   of	   a	   small	   fragment	   of	   a	   variant	   1	   sequence	   on	   a	   variant	   3	  background.	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  Figure	  1.9	   Schema	  of	   the	  recombination	  events	  in	  a	  region	  of	  10kb	   including	   the	  fHbp	  gene.	  The	  black	  box	  highlights	  the	  position	  of	  fHbp.	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  The	  structuring	  of	  the	  splits	  in	  a	  phylogenetic	  network	  of	  the	  fHbp	  sequences	  (Figure	  1.11)	  was	  also	  clearly	  related	  to	  the	  modularity	  of	  the	  gene.	  Five	  different	  contiguous	  portions	  of	  the	  molecule	   could	  be	  highlighted	   in	   the	   fHbp	   sequence	  alignment	   (f1-­‐f5	   in	  Figure	  1.10)	  that	  corresponded	  to	  the	  major	  splits	  in	  the	  network.	  f1+f2	  were	  the	  major	  contributors	  of	  the	  split	  between	  variant	  2	  and	  3,	  while	  f3+f5	  determined	  the	  split	  between	  variant	  1	  and	  variant	  2	  and	  3.	  All	  the	  portions	  segregated	  with	  variant	  1	  or	  3	  molecules	  (except	  f4	  which	  defined	   a	   portion	   of	   the	  molecule	   under	   a	   very	   different	   pattern	   of	   recombination)	   and	  variant	   2	   molecules	   could	   be	   described	   as	   a	   chimera	   of	   variant	   1	   and	   3	   molecules,	   as	  previously	   suggested	   [45]	   and	   supported	   by	   our	   analysis	   of	   the	   recombination	   events	  spanning	  this	  region.	  	  	  
	  
	  Figure	   1.10	   Multiple	   alignment	   of	   the	   fHbp	   variant	   1,	   2	   and	   3.	   Variant	   2	   sequences	   have	  originated	  by	   the	  substitution	  of	  a	  portion	  of	  a	  variant	  3	  fHbp	  by	  a	  foreign	  DNA	  sequence	  of	  350	   bp	   (length	   of	   the	   multiple	   alignment)	   from	   a	   variant	   1	   donor.	   Variant	   1	   isolates	   are	  labelled	  in	  black,	  variant	  2	  in	  green	  and	  variant	  3	  in	  red.	  The	  areas	  of	  the	  molecule	  variant	  1-­‐like	  are	  in	  white,	  the	  portions	  variant	  3-­‐like	  are	  highlighted	  in	  grey	  and	  the	  shared	  portion	  is	  in	   cyan.	   	   These	   different	   areas	   define	   5	   portions	   of	   the	   molecule	   (named	   f1-­‐f5)	   that,	   by	  different	  patterns	  of	  recombination,	  compose	  all	  the	  fHbp	  sequences.	  	  




Figure	   1.11	   Splits	   network	   representation	   of	   the	   fHbp	   gene.	   The	   highlighted	   portions	   f1-­‐f5	  refer	   to	   the	  multiple	   alignment	   shown	   in	   Figure	  1.10.	   Coloured	   labels	   indicate	   the	  different	  species	  of	  Neisseria.	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1.4.3 Conservation	  of	  NHBA	  Beside	   being	   present	   in	   all	   strains	   of	  N.	  meningitidis,	   conserved	   homologs	   of	   the	   NHBA	  coding	   gene	   were	   also	   found	   in	   N.	   lactamica,	   N.	   polysaccharea,	   N.	   gonorrhoeae	   and	   N.	  
flavescens	   (Table	   1.1).	   	   In	   all	   the	   species	   where	   NHBA	   was	   present,	   the	   entire	   locus	  harbouring	  the	  nhba	  gene	  was	  well	  conserved	  ().	  A	  highly	  conserved	  locus	  was	  also	  found	  in	  N.	  flavescens	  strain	  NRL30031	  H210,	  but	  the	  NHBA	  coding	  gene	  was	  frameshifted.	  In	  the	  only	   other	   available	   sequenced	   genome	   of	  N.	   flavescens	   the	   gene	  was	   absent.	   However,	  since	  the	  latter	  sequence	  was	  not	  complete,	  definitive	  conclusions	  could	  not	  be	  drawn.	  In	  other	   species,	   where	   the	  nhba	   homolog	  was	   absent	   (Table	   1.1),	   there	  was	   a	   very	  weak	  similarity	  hit,	  in	  any	  case	  inferior	  to	  30%	  sequence	  identity.	  	  While	  in	  most	  cases	  nhba	  sequences	  from	  different	  species	  did	  not	  segregate	  together	  in	  a	  phylogenetic	  tree	  (Figure	  1.13),	  all	  gonococcal	  nhba	  molecules	  clustered	  in	  a	  branch	  of	  the	  tree	  that	  was	  well	  supported	  by	  bootstrap	  testing	  (94%).	  In	  the	  rest	  of	  the	  tree,	  although	  it	  was	   possible	   to	   identify	   small	   groups	   of	   closely	   related	   sequences	   with	   high	   statistical	  support,	   most	   inner	   branches	   had	   very	   low	   value	   of	   bootstrap.	   In	   addition,	   the	  conservation	   of	   the	   nhba	   sequences	   within	  N.	  meningitidis	   [4,	   13,	   39]	   was	   of	   the	   same	  order	   of	  magnitude	   as	   the	   conservation	   across	   the	  whole	  Neisseria	   genus.	   These	   results	  provided	  further	  support	  to	  the	  existence	  of	  a	  high	  rate	  of	  genetic	  exchange	  between	  the	  
	  
Figure	  1.12	  Alignment	  of	  the	  nhba	   locus	   in	  N.	  lactamica	   strain	  020-­‐06,	  N.	  meningitidis	  strain	  MC58,	  N.	  gonorrhoeae	  strain	  FA	  1090	  and	  N.	  polysaccharea	  strain	  ATCC	  43768.	  The	  nhba	  gene	  is	  indicated	  in	  green.	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different	   species	   that	   homogenize	   the	   distribution	   of	   the	   NHBA	   molecules	   within	   the	  
Neisseria	  genus,	  with	  the	  possible	  exception	  of	  gonococcus.	  A	  phylogenetic	  network	  analysis	  evidenced	  the	  influence	  of	  homologous	  recombination	  on	  the	   complex	   evolutionary	   history	   of	   this	   set	   of	   sequences	   (Figure	   1.14),	   since	   it	   was	  impossible	   to	   separate	   phylogenetic	   clades	   corresponding	   to	   the	   species.	   The	   only	  exceptions	   were	   the	   strains	   of	   gonococcus	   that	   were	   grouped	   in	   a	   separated	   branch,	  although	  we	  found	  evidences	  of	  reticulate	  evolution	  also	  between	  the	  gonococcal	  branch	  and	  the	  other	  neisseriae.	  We	  also	  analysed	  the	  evidences	  of	  recombination	  events	   in	   the	  region	   including	   10kbp	   upstream	   and	   downstream	   of	   the	   gene.	   In	   accordance	  with	   the	  network	   analysis	   of	   the	   gene	   sequences,	   the	   pattern	   of	   homologous	   recombination	  was	  very	  complex,	  and	  we	  found	  many	  distinct	  events	  overlapping	  the	  nhba	  gene	  (Figure	  1.15).	  	  The	   level	   of	   conservation	   of	   two	   important	   functional	   motifs	   described	   for	   the	   NHBA,	  namely	  the	  lipobox	  motif	  (LXXC)	  and	  the	  Arg-­‐rich	  heparin-­‐binding	  motif	  (RFRRSARSRRS),	  was	  checked.	  The	  lipobox	  motif	  was	  conserved	  in	  all	  strains.	  The	  Arg-­‐rich	  heparin-­‐binding	  motif	  was	  well	   conserved	   in	   the	   central	   part	   (RSARSR).	  Where	  present,	   the	   three	   initial	  amino	   acids	  of	   the	  motif	   (RFR)	  were	   less	   conserved.	   In	   all	  Gonococcal	   strains,	   in	   one	  N.	  
lactamica	  (strain	  Y92	  1009),	  in	  N.	  polysaccharea	  and	  in	  three	  N.	  meningitidis	  strains	  (8013,	  alpha14	   and	   N1568)	   a	   deletion	   of	   7-­‐8	   amino	   acids	   (relative	   to	   the	   MC58	   protein)	   was	  present,	   that	   included	   the	   three	   initial	   amino	   acids	   (RFR)	   of	   the	   heparin-­‐binding	  motif.	  This	  region,	  located	  upstream	  of	  the	  heparin	  binding	  motif,	  is	  the	  cleavage	  site	  of	  the	  NalP	  protein	  [17]	  and	  was	  described	  as	  variable	  in	  gonococcus	  [14].	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Figure	  1.13	  Maximum	  Likelihood	  phylogenetic	   tree	  of	  the	  nhba	  gene.	  The	  tree	  was	  obtained	  using	   the	  Kimura	  2	  parameters	  model	  with	  Gamma	  correction.	  The	  average	  gene	  variability	  was	  Pi	  =	  0.084	  (s.e.	  0.004).	   	  Gonococcus	  formed	  a	  monophyletic	  branch	  closely	  related	  to	  the	  rest	  of	   the	   isolates.	   The	  other	   species,	  N.	  polysaccharea,	  N.	  lactamica	  and	  N.	  flavescens	  were	  scattered	  through	  the	  entire	  tree.	  Coloured	  circles	  and	  labels	  indicate	  the	  different	  species	  of	  
Neisseria.	   The	   (§)	   symbol	   indicates	   sequences	   that	   were	   downloaded	   from	   the	   BigsDB	  database,	  otherwise	  from	  GenBank.	  The	  (#)	  symbol	  indicates	  genes	  that	  were	  at	  the	  border	  of	  a	  contig.	  Asterisks	  (*)	  indicate	  genes	  that	  were	  frameshifted.	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Figure	   1.14	   Splits	   network	   representation	   of	   the	   nhba	   gene.	   Coloured	   labels	   indicate	   the	  different	  species	  of	  Neisseria.	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  Figure	   1.15	   Schema	   of	   the	   recombination	   events	   in	   a	   region	   including	   10kb	   of	   sequence	  upstream	  and	  downstream	  of	  the	  nhba	  gene.	  The	  black	  box	  highlights	  the	  position	  of	  nhba.	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1.4.4 Conservation	  of	  NadA	  The	  nadA	   gene	  was	  present	   in	  12	  of	   the	   sequenced	   strains	   of	  N.	  meningitidis	   (see	  Table	  1.1).	   In	   two	   strains	   the	   coding	   sequence	   of	   the	   nadA	   homolog	   was	   interrupted	   by	   a	  premature	   stop	   codon	   introduced	   by	   a	   frameshift.	   In	   another	   strain	   (M6190)	  nadA	  was	  disrupted	  by	  the	  IS4	  insertion.	  In	  two	  cases,	  the	  coding	  sequence	  of	  nadA	  was	  interrupted	  by	  the	  border	  of	  a	  contig,	  and	  the	  functionality	  of	  the	  gene	  could	  not	  be	  established.	  	  We	  found	  no	  homolog	  of	  the	  nadA	  gene	  in	  N.	  lactamica	  and	  N.	  polysaccharea,	  although	  in	  those	   species,	   as	  well	   as	   in	   the	  N.	  meningitidis	   strains	   that	  do	  not	  harbour	   the	   gene,	   the	  locus	  was	  well	  conserved	  (Figure	  1.16),	  suggesting	  that	  the	  nadA	  gene	  was	  the	  result	  of	  a	  recent	   insertion	   that	   left	   the	   neighbouring	   genes	   unchanged	   [21].	   We	   found	   an	   intact	  homolog	  of	  nadA	  in	  one	  strain	  of	  N.	  cinerea,	  while	  in	  another	  strain	  we	  could	  reconstruct	  a	  
nadA	   gene	   by	   joining	   two	   distinct	   contigs	   that	   contained,	   respectively,	   850bp	   of	   the	   N-­‐term	  and	  600bp	  of	  the	  C-­‐term	  of	  the	  molecule.	  However	  the	  integrity	  of	  the	  gene	  could	  not	  be	  established.	  In	  two	  N.	  cinerea	  strains,	  	  fragments	  of	  nadA	  could	  be	  found	  small	  contigs,	  but	  it	  was	  impossible	  to	  establish	  whether	  the	  gene	  was	  present.	  Finally,	  in	  one	  N.	  cinerea	  strain	   the	   locus	   was	   conserved	   but	   nadA	  was	   replaced	   by	   a	   gene	   coding	   for	   a	   small	  hypothetical	   ORF.	  When	  we	   used	   the	   concatenated	   pseudogene	   and	   the	   complete	   nadA	  
	  Figure	  1.16	  Alignment	   of	   the	  nadA	   locus	   in	  N.	  meningitidis	   of	   serogroup	   A	   strain	   Z2491,	  N.	  
meningitidis	   of	   serogroup	   B	   strain	   MC58	   e	   N.	   lactamica	   strain	   020-­‐06.	   The	   nadA	   gene	   is	  indicated	  in	  green.	  Although	  the	  locus	  is	  well	  conserved,	  the	  nadA	  gene	  is	  missing	  both	  in	  N.	  
meningitidis	   of	   serogroup	  A	  and	   in	  N.	  lactamica.	   In	  N.	  cinerea	  ATCC_14685	   the	  nadA	  gene	   is	  interrpupted	  by	  a	  contig	  edge,	  in	  N.	  cinerea	  CCUG346T	  the	  gene	  is	   intact.	   In	  both	  strains	   the	  gene	  is	  placed	  in	  the	  same	  locus	  of	  N.	  meningitidis	  of	  serogroup	  B	  strain	  MC58.	  	  
	  	  	  	  
31	  
from	  N.	   cinerea	   to	   build	   a	   phylogenetic	   tree	   (Figure	   1.17),	  we	   found	   that	   the	  N.	   cinerea	  sequences	   were	   related	   to	   the	   nadA-­‐4/5	   forms	   from	   N.	   meningitidis	   [13].	   In	   all	   other	  species	   the	   locus	   was	   not	   conserved.	   In	   N.	   lactamica,	   N.	   mucosa	   and	   N.	   sicca,	   a	   weak	  similarity	   hit	   (less	   than	   45%	   sequence	   identity)	   was	   present,	   but	   the	   homology	   was	  limited	  to	  a	  C-­‐term	  portion	  of	  the	  molecule	  of	  about	  120	  aa,	  that	  is	  common	  to	  a	  family	  of	  YadA-­‐like	  surface	  proteins	  (Table	  1.1)	  and	  not	  specific	  of	  nadA.	  	  The	  analysis	  of	   the	  presence	  of	   recombination	   revealed	  a	   limited	  number	  of	   events	   that	  related	  the	  formation	  of	  the	  meningococcal	  nadA-­‐4	  and	  5	  molecules	  to	  a	  contribution	  from	  a	  donor	  similar	  to	  the	  N.	  cinerea	  nadA	  (data	  not	  shown).	  	  	   	  
	  Figure	  1.17	  Maximum	  Likelihood	  phylogenetic	   tree	  of	   the	  nadA	  gene.	  The	  tree	  was	  obtained	  using	   the	   Kimura	   2	   parameters	   model	   with	   Gamma	   correction.	   The	   sequence	   from	   the	   N.	  
cinerea	   ATCC	   14685	   strain	   was	   obtained	   by	   joining	   two	   fragments	   at	   the	   border	   of	   two	  distinct	  contigs,	  and	  it	  was	  therefore	  not	  possible	  to	  assess	  the	  integrity	  of	  the	  gene.	  Coloured	  circles	   and	   labels	   indicate	   the	   different	   species	   of	   Neisseria.	   The	   (§)	   symbol	   indicates	  sequences	   that	  were	  downloaded	   from	   the	  BigsDB	  database,	   otherwise	   from	  GenBank.	  The	  (#)	  symbol	  indicates	  genes	  that	  were	  at	  the	  border	  of	  a	  contig.	  The	  (+)	  symbol	  indicates	  genes	  that	  were	  interrupted	  by	  the	  IS4.	  	  Asterisks	  (*)	  indicate	  genes	  that	  were	  frameshifted.	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1.4.5 Conservation	  of	  GNA1030	  The	   GNA1030	   gene	   was	   present	   in	   all	   analyzed	   strains,	   with	   the	   exception	   of	   the	   draft	  genome	   of	   N.	   wadsworthii	   9715.	   In	   N.	   polysaccharea	   ATCC_43768,	   the	   gene	   was	  interrupted	   at	   the	   border	   of	   a	   contig.	   In	   two	   strains	   of	   gonococcus	   (PID332	   and	  SK_93_1035)	  the	  poly-­‐A	  stretch	  following	  the	  ATG	  start	  codon	  introduced	  an	  Adenine	  that	  was	  responsible	  for	  a	  frameshift	  of	  the	  gene.	  In	  the	  other	  species	  the	  gene	  sequences	  were	  well	   conserved	   and	   the	   average	   gene	   variability	   of	   the	   whole	  Neisseria	   genus	   was	   Pi	   =	  0.095	  (s.e.	  0.005).	  A	  phylogenetic	  tree	  based	  on	  the	  aligned	  sequences	  is	  shown	  in	  Figure	  1.18.	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  Figure	  1.18	  Maximum	  Likelihood	  phylogenetic	  tree	  of	   the	  GNA1030.	  Coloured	   labels	   indicate	  the	  different	  species	  of	  Neisseria.	  The	  (§)	  symbol	   indicates	  sequences	  that	  were	  downloaded	  from	  the	  BigsDB	  database,	  otherwise	  from	  GenBank.	  Genes	   that	  were	   frameshifted	  or	  at	   the	  border	  of	  a	  contig	  are	  indicated	  by	  asterisk	  (*).	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1.4.6 Conservation	  of	  GNA2091	  The	  GNA2091	  gene,	  predicted	  to	  code	  for	  a	  haemolysin,	  was	  present	  in	  all	  species.	  In	  both	  
N.	  weaveri	  LMG_5135	  and	  ATCC_51223	  the	  gene	  was	  interrupted	  at	  the	  border	  of	  a	  contig.	  The	   predicted	   start	   codon	   (ATG)	   was	   not	   always	   conserved	   but	   was	   in	   some	   cases	  replaced	  by	  the	  GTG	  (Valine)	  or	  AAG	  (Lysine)	  codons.	  	  The	  gene	  was	  always	  in	  frame	  and	  well	   conserved	   in	   the	   Neisseria	   genus	   (Pi	   =	   0.128,	   s.e.	   0.005).	   The	   phylogenetic	  reconstruction	  of	  the	  molecule	  is	  shown	  in	  Figure	  1.19.	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  Figure	  1.19	  Maximum	  Likelihood	  phylogenetic	  tree	  of	   the	  GNA2091.	  Coloured	   labels	   indicate	  the	  different	  species	  of	  Neisseria.	  The	  (§)	  symbol	  indicates	  sequences	  that	  were	  downloaded	  from	  the	  BigsDB	  database,	  otherwise	  from	  GenBank.	  Genes	   that	  were	   frameshifted	  or	  at	   the	  border	  of	  a	  contig	  are	  indicated	  by	  asterisk	  (*).	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1.5 Discussion	  and	  conclusions	  The	   genus	   Neisseria	   includes	   a	   large	   group	   of	   bacteria,	   some	   of	   which	   are	  responsible	   for	   life-­‐threatening	   diseases	   in	   humans,	   while	   others	   are	   mainly	   harmless	  colonizers.	   	   We	   have	   studied	   the	   distribution	   of	   fHbp,	   nhba	   and	   nadA,	   three	   antigens	  included	  in	  the	  4CMenB	  vaccine,	  in	  the	  available	  genome	  sequences	  of	  the	  commensal	  and	  pathogenic	  neisseriae.	  We	  also	  studied	  GNA2091	  and	  GNA1030	  proteins,	   included	   in	   the	  4CMenB	   vaccine	   as	   fusion	   proteins	   with	   fHbp	   (GNA2091-­‐fHbp)	   and	   NHBA	   (NHBA-­‐GNA1030).	   fHbp	   was	   present	   in	   one	   of	   its	   three	   major	   variants	   in	   all	   strains	   of	   N.	  
meningitidis,	   in	  N.	   gonorrhoeae	   and	   in	   all	   commensal	   human	   neisseriae	   that	   have	   been	  sequenced	   to	   date,	   except	   N.	   lactamica.	   All	   strains	   of	   N.	   gonorrhoeae	   and	   of	   N.	  
polysaccharea	  harboured	  a	  variant	  3,	  while	  strains	  of	  N.	  cinerea	  harboured	  close	  homologs	  of	  a	  N.	  meningitidis	  variant	  1.	  It	  was	  not	  possible	  to	  assess	  unambiguously	  in	  which	  species	  the	  protein	  evolved	  primarily,	  and	  all	  hypotheses	  involved	  at	  least	  one,	  but	  possibly	  two,	  events	   of	   inter-­‐species	   recombination.	   Given	   the	   relatively	   lower	   recombination	   rate	  between	  N.	  meningitidis	   and	  N.	  gonorrhoeae	   [9],	   and	   the	   fact	   that	   a	   fHbp	   gene	   variant	   3	  exists	  also	  in	  N.	  polysaccharea,	   it	   is	   likely	  that	  a	   fHbp	  variant	  3	  was	  present	  in	  their	  most	  recent	  common	  ancestor.	  We	  also	  found	  evidences	  that	  the	  fHbp	  gene	  variant	  1	  evolved	  in	  
N.	  cinerea	  and	  was	  introduced	  in	  N.	  meningitidis	  by	  a	  recombination	  event	  involving	  also	  the	   neighbouring	   cbbA	   gene.	   Finally,	   sequence	   analysis	   suggested	   that	   one	   more	  homologous	  recombination	  event	  has	  generated	  the	  variant	  2	  fHbp	  by	  inserting	  a	  variant	  1	  fragment	  on	  a	  variant	  3	  background.	  	  A	  distribution	  similar	  to	  fHbp	  was	  found	  for	  nhba,	  which	  was	  absent	  from	  N.	  cinerea,	  while	  it	   was	   present	   in	   N.	   lactamica.	   A	   fully	   parsimonious	   pattern	   of	   inheritance	   was	   not	  compatible	  with	  the	  phylogenetic	  tree	  of	  the	  gene.	  Also,	  the	  gene	  was	  present	  in	  all	  strains	  of	   N.	   gonorrhoeae,	   and	   its	   sequences	   showed	   little	   variability	   within	   this	   species.	   This	  result	  was	   compatible	  with	   the	  overall	   low	  variability	  of	   the	  genomes	  of	  N.	  gonorrhoeae	  and	   suggested	   a	   recent	   diversification	   of	   the	   gonococcus	   from	  N.	  meningitidis.	   The	  nhba	  gene	  showed	  low	  variability	  within	  N.	  meningitidis	  [4,	  13,	  39],	  and	  sera	  of	  mice	  vaccinated	  with	   one	   variant	   were	   shown	   to	   be	   bactericidal	   against	   heterologous	   strains	   [3].	  Interestingly,	   the	   heparin-­‐binding	  motif	   was	   only	   partially	   conserved	   across	   all	   species	  where	  the	  gene	  was	  present.	  The	  site	  of	  cleavage	  of	  NHBA	  by	  NalP,	  situated	  upstream	  of	  the	   heparin	   binding	   region,	   was	   not	   conserved,	   suggesting	   a	   different	   protein	   post	  translation	  processing.	  	  The	  gene	  coding	  for	  NadA	  is	  part	  of	  an	  independent	  genetic	  unit	  [21],	  which	  consists	  of	  a	  promoter	  region,	  the	  coding	  sequence	  and	  a	  terminator	  region.	  nadA,	  was	  present	  only	  in	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a	  portion	  of	   the	  N.	  meningitidis	   strains,	  and	  was	  never	   found	   in	  any	  other	  commensal	  or	  pathogenic	   neisseriae,	   with	   the	   exception	   of	   two	   strains	   of	   N.	   cinerea.	   Analysis	   of	   the	  sequences	  immediately	  adjacent	  to	  this	  genetic	  unit	  showed	  that	  the	  segment	  was	  always	  flanked	   by	   direct	   repeats,	   indicating	   that	   a	   mechanism	   of	   recombination	   could	   have	  determined	   its	  distribution	  amongst	   the	  meningococcal	   lineages.	   	  Finally,	  homologues	  of	  GNA1030	  and	  GNA2091	  were	  present	  and	  well	  conserved	  in	  most	  isolates	  of	  the	  Neisseria	  genus.	  	  Taken	   together,	   these	   findings	   highlight	   the	   complex	   evolutionary	   history	   of	   the	   human	  neisseriae.	   With	   the	   exception	   of	   N.	   gonorrhoeae,	   the	   human	   neisseriae	   are	   carried	  asymptomatically	  in	  the	  nasopharynx	  of	  healthy	  individuals.	  It	  has	  long	  been	  known	  that	  homologous	  recombination	   is	   the	  main	  process	  contributing	  to	   the	  genomic	  evolution	  of	  
N.	   meningitidis,	   and	   that	   some	   antigens	   can	   be	   exchanged	   between	   pathogenic	   and	  commensal	   species	   [46].	  We	   found	   that,	  when	  present,	   the	   sequences	  of	   fHbp,	  nhba	   and	  
nadA	   from	   other	   species	   of	   the	  Neisseria	   genus	   do	   not	   introduce	   radically	   new	   variants	  when	  compared	  to	  the	  variability	  already	  present	  in	  N.	  meningitidis.	  	  The	   distribution	   of	   the	   4CMenB	   vaccine	   antigens	   in	   the	   commensal	   neisseriae	   suggests	  that	   vaccination	   could	   have	   an	   impact	   on	   the	   composition	   of	   the	   commensal	   flora.	   In	  particular,	  since	  the	  variability	  of	  nhba	  across	  the	  different	  neisseriae	  (N.	  gonorrhoeae,	  N.	  
lactamica	   and	   N.	   polysaccharea)	   was	   similar	   to	   the	   intra-­‐species	   variability	   within	   N.	  
meningitidis,	   a	   recombinant	   vaccine	  based	  on	  nhba	   could	  have	   an	   impact	   on	   the	   species	  harbouring	   this	   protein.	   However,	   as	   recently	   shown	   for	   the	   4CmenB	   vaccine	   [33],	   the	  ability	   of	   vaccine-­‐induced	  antibodies	   to	  mediate	  killing	  depends	  on	   their	   ability	   to	   react	  with	  the	  variant/peptide	  present	   in	  the	  vaccine	  and	  on	  the	  amount	  of	  antigen	  expressed	  by	   a	   given	   strain.	   The	   latter	  might	   vary	  within	   and	   between	   species	   in	   response	   to	   yet	  unknown	   environmental	   factors,	   as	   recently	   demonstrated	   for	   NadA	   [34,	   40].	   Other	  factors,	   like	   surface	  accessibility	  must	  also	  be	   taken	   into	  account	   [13,	  20,	  47].	  Therefore	  genetic	   typing	   is	   not	   sufficient	   to	   predict	   strain	   coverage	   and	   further	   studies	   will	   be	  needed	  to	  evaluate	  whether	  this	  vaccine	  will	  have	  any	  impact	  on	  commensal	  strains.	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Chapter	  2. Conservation	  of	  Meningococcal	  antigens	   in	  carrier	  
and	   pathogenic	   isolates	   of	  N.	  meningitidis	   collected	   in	   the	  
Czech	  Republic	  in	  1993.	  
2.1 Abstract	  The	   differences	   between	   Neisseria	   meningitidis	   strains	   isolated	   in	   healthy	  individuals	   and	   in	   people	   affected	   by	   meningococcal	   infection	   is	   of	   great	   interest	   for	  molecular	  epidemiology,	  in	  particular	  to	  understand	  the	  etiology	  of	  meningococcal	  disease	  and	   its	   relationships	   with	   genetic	   characteristics	   of	   meningococci.	   In	   this	   work,	   we	  analysed	  and	  compared	  the	  genetic	  variability	  of	  three	  surface	  antigens,	  main	  components	  of	  the	  4CMenB	  vaccine,	   in	  all	  pathogenic	  isolates	  collected	  in	  the	  Czech	  Republic	  in	  1993	  and	  a	  larger	  sample	  of	  carriage	  strains	  collected	  over	  the	  same	  time	  period.	  	  The	   genetic	   variability	   of	   three	   meningococcal	   antigens,	   fHbp,	   NadA,	   and	   NHBA	   was	  evaluated	  in	  266	  strains	  isolated	  in	  the	  Czech	  Republic.	  Full	  gene	  sequences	  were	  assessed	  for	  nhba	  and	   fHbp.	  nadA	   gene	  presence	  was	  determined	  by	  PCR	  amplification.	  The	  nhba	  and	  fHbp	  sequences,	  and	  the	  nadA	  presence-­‐absence	  genotypes,	  were	  compared	  between	  isolates	   derived	   from	   healthy	   individuals	   and	   from	   disease	   cases.	   Also,	   any	   existing	  relationship	   between	   the	   diversity	   of	   each	   protein	   and	   neisserial	   clonal	   complexes	  was	  investigated.	   In	   particular,	   fHbp	   diversification	   was	   studied	   within	   the	   ST-­‐41/44	   clonal	  complex	  structure,	  where	  carriage	  and	  disease	  isolates	  were	  peculiarly	  distributed.	  	  Both	  fHbp	  and	  NHBA	  showed	  a	  high	  degree	  of	  relatedness	  with	  the	  structuring	   in	  clonal	  complexes	   typical	   of	   the	   neisserial	   population	   and	   a	   diversified	   distribution	   in	   strains	  from	   healthy	   subjects	   or	   disease	   cases.	   In	   particular,	   the	   fHbp	   main	   variant	   2	   was	  particularly	   associated	  with	   carriage	   as	  well	   as	   specific	   NHBA	   peptide	   sequences.	   NadA	  was	  confirmed	   to	  be	  present	  mostly	   in	  pathogenic	  strains,	   rather	   than	   in	  carrier	  strains.	  Interesting	   differences	   in	   the	   antigenic	   repertoires	   between	   carriage	   and	   pathogenic	  strains	  were	   found	   in	   almost	   all	   clonal	   complexes:	   ST-­‐41/44,	   ST-­‐92,	   ST-­‐106	  and	  ST-­‐116	  displayed	  antigenic	  repertoires	  that	  appeared	  to	  be	  associated	  with	  carriage	  only.	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2.2 Introduction	  
Neisseria	   meningitidis	   (Nm)	   is	   a	   human-­‐specific	   pathogen	   that	   causes	   sudden	  invasive	   disease	   that	   can	   result	   in	   permanent	   disability	   or	   death	   in	   otherwise	   healthy	  people.	   Despite	   this	   association	   with	   such	   devastating	   disease,	   Nm	   often	   colonizes	   the	  oropharyngeal	  mucosa	  of	  humans	  without	  affecting	   the	  host.	  Normal	   colonisation	  of	   the	  oropharynx,	   commonly	   called	   carriage,	   occurs	   with	   variable	   frequency	   in	   healthy	  individuals,	  typically	  between	  1	  to	  10%,	  and	  can	  rise	  to	  100%	  in	  social	  communities	  living	  in	  close	  contact	  such	  as	  military	  recruits	  or	  students	  [48].	  During	  asymptomatic	  carriage,	  the	  meningococcal	   colonisation	   is	   a	   complex	   state	   and	   possibly,	   it	   is	   not	   limited	   to	   the	  mucosal	  surface	  but	  also	  extends	  itself	  to	  the	  tonsillar	  tissue	  [49].	  However,	  bacteria	  that	  cross	  epithelium	  and	  escape	  from	  host	  defences	  may	  replicate	  rapidly	  and	  spread	  into	  the	  blood,	   causing	   septicaemia,	   or	   reach	   and	   cross	   the	   vascular	   endothelium	   of	   the	   brain,	  infecting	  the	  meninges	  and	  the	  cerebrospinal	  fluid.	  Different	  complex	  mechanisms	  permit	  
Nm	  to	  escape	  from	  the	  immune	  system,	  by	  reducing	  recognition	  of	  the	  bacterial	  surface	  by	  the	   host	   (i.e.	   the	   presence	   of	   the	   capsule,	   or	   other	   surface	   exposed	   phase-­‐variable	  proteins),	   by	   redirecting	   immune	   response	   (i.e.	   producing	   outer	   membrane	   vesicles	   or	  OMV	  carrying	   important	   immunodominant	  proteins),	  or	  by	   inhibiting	   the	  host	   response,	  for	  example	  by	  reducing	  the	  complement	  cascade	  activation.	  For	   mechanisms	   that	   are	   directly	   related	   to	   specific	   molecular	   components	   of	   the	  bacterium,	   e.g.	   the	   capsule	   or	   specific	   surface-­‐exposed	   proteins,	   the	   monitoring	   of	   the	  molecular	  variability	  among	  the	  isolates	  can	  help	  in	  understanding	  the	  differences	  during	  carriage	  and	  disease	   (if	   any),	  both	   functionally	  and	  epidemiologically.	  Such	  observations	  become	  more	  important	  when	  considering	  strategies	  for	  developing	  vaccines	  against	  Nm.	  	  	  Vaccines	   against	   meningococcal	   serogroups	   A,	   C,	   W-­‐135	   and	   Y	   are	   based	   on	   capsular	  polysaccharide,	   a	   strategy	   that	   fails	   against	   Serogroup	   B	   (MenB),	   because	   its	   capsule,	   a	  homopolymer	  of	  α2-­‐8-­‐linked	  sialic	  acid,	  resembles	  a	  human	  neural	  cell	  adhesion	  molecule,	  NCAM-­‐1	  [50].	  	  As	  a	  consequence,	  the	  B	  capsule	  is	  poorly	  immunogenic,	  and	  the	  use	  of	  the	  capsule	   as	   a	   vaccine	   component,	   could	   raise	   an	   autoimmune	   response.	   Earlier	   MenB	  vaccines	  based	  on	  OMV	  successfully	   limited	  clonal	  outbreaks	   in	  Cuba,	  Norway,	  and	  New	  Zealand	   [51-­‐53].	   OMVs	   include	   surface	   exposed	   proteins	   such	   as	   PorA,	   which	   is	   the	  immunodominant	   antigen.	   PorA	   is	   structurally	   hypervariable,	   it	   has	   a	   phase-­‐variable	  expression	  and	   shows	  only	   limited	   cross	   reactivity	  between	  variants	   [51,	  52,	  54],	  which	  limits	  the	  use	  of	  these	  vaccines.	  Current	   MenB	   vaccine	   development	   relies	   on	   recombinant	   surface	   protein	   fusions	   and	  combinations.	  The	  4CMenB	  vaccine	   (approved	   in	  Europe	  under	   the	  commercial	  name	  of	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Bexsero®)	   [1]	   is	   a	   multicomponent	   formulation	   including	   three	   recombinant	   proteins:	  factor	  H	  binding	  protein	  (fHbp;	  genome	  derived	  Neisseria	  antigen	  (GNA)1870;	  lipoprotein	  (LP)2086)	   [3,	   10,	   39],	  N.	  meningitidis	   adhesin	   A	   (NadA;	   GNA1994)	   [22]	   and	   Neisserial	  Heparin	   Binding	   Antigen	   (NHBA;	   GNA2132)	   [55];	   and	   the	   outer	   membrane	   vesicles	  (OMVs)	  derived	  from	  strain	  NZ98/254	  [53].	  	  fHbp	   is	   a	   surface-­‐exposed	   lipoprotein	   that	   binds	   human	   factor	   H,	   a	   	   major	   negative	  regulator	   of	   the	   complement	   alternative	   pathway	   [10],	   and	   it	   allows	   meningococci	   to	  evade	  innate	  host	  defences.	  The	   fHbp	  gene	  is	  typically	  present	  in	  meningococcal	   isolates,	  with	  three	  main	  protein	  variants	  (1–3)	  ,	  that	  	  exhibit	  a	  limited	  cross-­‐reactivity	  [3,	  39].	  	  NHBA	   is	   a	   lipoprotein	   [56]	   able	   to	   bind	   heparin	   in	  vitro	   [55].	   The	   gene	   is	   present	   in	   all	  meningococcal	   isolates	   analysed	   so	   far	   [18,	   39,	   57]	   and	   despite	   the	   sequence	   diversity	  observed,	   NHBA	   induces	   bactericidal	   antibodies	   that	   are	   cross-­‐protective	   against	   most	  strains	  tested	  [1].	  NadA	   belongs	   to	   the	   Oligomeric	   Coiled-­‐coil	   Adhesin	   class	   of	   trimeric	   proteins	   [21].	   The	  
nadA	   gene	   occurs	   in	   approximately	   50%	   of	   pathogenic	   MenB	   strains,	   but	   in	   nearly	   all	  strains	   of	   the	   hypervirulent	   clonal	   complexes	   ST-­‐32,	   ST-­‐11	   and	   ST-­‐8	   [22].	   NadA	   was	  described	  to	  have	  5	  molecular	  forms,	  grouped	  in	  two	  main	  groups,	  with	  the	  form	  NadA-­‐4	  generally	  associated	  to	  carrier	  strains	  [22].	  	  Each	  of	  these	  proteins	  has	  shown	  immunogenicity	  in	  animal	  studies	  and	  clinical	  trials	  [1].	  A	  vaccine	  based	  on	  the	   fusion	  of	   two	  different	  variants	  of	   the	   fHbp	  protein	   is	  also	  under	  development	   [15].	   Meningococcal	   epidemiology	   is	   commonly	   monitored	   by	   molecular	  epidemiological	  tools	  like	  Multilocus	  Sequence	  Typing	  (MLST)	  [58],	  which	  is	  based	  on	  the	  sequencing	  of	  7	   specific	  housekeeping	  genes.	  MLST	  assignment	   is	  used	   to	  define	  groups	  (clonal	  complexes,	  cc)	  of	  strictly	  related	  isolates	  derived	  from	  a	  common	  ancestor.	  MLST	  clonal	  complexes	  have	  aided	  in	  the	  recognition	  and	  epidemiological	  monitoring	  of	  specific	  hyperinvasive	   meningococcal	   lineages.	   Other	   technique,	   like	   determination	   of	   capsular	  group,	  of	  strain	  subtype	  (PorA	  variable	  regions),	  or	  FetA	  sequencing	  [59]	  [60]	  can	  also	  be	  used	   to	   complement	   MLST	   typing	   [58].	   More	   recently,	   sequencing	   of	   fHbp,	   has	   been	  introduced	  as	  an	  additional	  molecular	  tracer	  of	  meningococcal	  strain	  diversity	  [61].	  	  	  In	   this	   study,	  we	  analysed	  and	   compared	   the	  presence	  and	   the	  genetic	   variability	  of	   the	  fHbp,	  NadA	  and	  NHBA	  proteins	  in	  all	  meningococcal	  isolates	  belonging	  to	  a	  Czech	  Republic	  collection,	   which	   is	   a	   reference	   for	   epidemiological	   studies	   on	   carriage	   [62-­‐66].	   In	  particular,	   we	   analysed	   all	   carriage	   strains	   isolated	   in	   1993,	   together	   with	   all	   isolates	  causing	  a	  disease	  event	  during	  the	  same	  year.	  The	  association	  of	  specific	  clonal	  complexes	  with	   carriage	   or	   disease	   has	   been	   observed	   in	   the	   same	   strain	   panel	   [63].	   We	   further	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investigated	   this	   aspect,	   by	   looking	  at	   the	   sequence	  variability	  of	   fHbp	   in	   carrier	   strains	  belonging	  to	  clonal	  complex	  ST-­‐41/44,	  and	  compared	  the	  results	  with	  the	  ones	  from	  Nm	  isolates	  belonging	  to	  the	  same	  clonal	  complex	  from	  other	  epidemiological	  studies.	  In	  total	  255	  strains	  of	  clonal	  complex	  ST-­‐41/44,	  from	  carriage	  and	  from	  disease,	  were	  analysed.	  	  
2.3 Methods	  
2.3.1 Isolates	  panel	  A	   systematic	   carrier	   survey	   was	   performed	   in	   the	   Czech	   Republic.	   Meningococci	   were	  isolated	  from	  throat	  swab	  specimens	  in	  the	  1970s	  (610	  isolates),	  1980s	  (99	  isolates),	  and	  1990s	   (345	   isolates)	   [65,	   66].	   The	   samples	   were	   from	   volunteers	   of	   all	   age	   groups,	  attending	   schools	   and	   workplaces	   from	   locations	   covering	   all	   over	   the	   country.	   We	  selected	  for	  the	  analysis	  all	  meningococcal	  isolates	  (213	  carriage	  and	  53	  disease)	  collected	  during	  the	  year	  1993.	  Swabs	  were	  inoculated	  onto	  Thayer-­‐Martin	  selective	  medium	  and	  incubated	  at	  37°C	  in	  5%	  CO2	  for	  48h.	  Resistant	  colonies	  were	  subcultured	  onto	  heated	  blood	  Mueller-­‐Hinton	  agar.	  Species	   confirmation	   was	   performed	   by	   Gram	   staining,	   oxidase	   reaction,	   and	   with	   the	  Neisseria	  4H	  system	  (Sanofi	  Diagnostics	  Pasteur)	  or	  API	  NH	  system	  (bioMe´rieux)	  panels	  of	   biochemical	   tests.	   No	   sampled	   individuals	   had	   known	   contact	   with	   patients	   with	  invasive	  meningococcal	  disease.	   	   Chromosomal	  DNA	  was	  extracted	   from	  stored	   samples	  by	  using	  the	  Isoquick	  Nucleic	  Acid	  Extraction	  Kit	  (Orca	  Research).	  To	   study	   the	   variability	   and	   distribution	   of	   fHbp,	   within	   clonal	   complex	   ST-­‐41/44	  (cc41/44),	   we	   composed	   for	   comparison	   a	   cc41/44	   strain	   panel	   including:	   32	   strains	  collected	   in	   Czech	   Republic,	   in	   1993;	   14	   isolates	   belonging	   to	   the	   107	  MLST	   Reference	  disease/carriage	   strains	   database	   [58,	   61];	   17	   invasive	   strains	   collected	   in	   Sweden,	   in	  2000/2001	   [18];	   171	   cc41/44	   invasive	   isolates	   collected	   in	   England	   and	   Wales,	   in	  2007/2008	   [5];	   21	   invasive	   isolates	   from	   the	   Novartis	   reference	   strain	   panel,	   collected	  worldwide	  [39].	  As	  for	  a	  meningococcal	  population	  analysis,	  distribution	  of	  2492	  cc41/44	  disease/carriage	  isolates	  was	  evaluated	  from	  MLST	  database	  (updated	  on	  January	  2012).	  
2.3.2 Serogrouping	  and	  molecular	  typing	  All	  strains	  were	  genetically	  typed	  by	  MLST	  following	  standards	  procedures	  described	  on	  the	  Neisseria	  MLST	  website	  [67].	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All	   Czech	  Republic	   strain	   capsular	   groups	   and	   sub-­‐types	  were	   determined	   serologically.	  Capsular	  group	  was	  also	  confirmed	  by	  sequencing	  the	  siaD	  gene	  of	  153	  strains.	  For	  strains	  with	   conflicting	   serogroup	   results	   between	   these	   methods,	   we	   considered	   only	   data	  obtained	   by	   sequencing.	   	   All	   strains	   were	   also	   characterized	   by	   sequencing	   variable	  regions	  (VR)	  1	  and	  2	  of	  the	  porA	  gene	  [60]	  and	  the	  variable	  region	  of	  the	   fetA	  gene	  [59].	  fHbp,	  NHBA	  and	  NadA	  genes,	  the	  latter	  in	  a	  limited	  number	  of	  cases	  only,	  were	  amplified	  and	   sequenced	   as	   described	   by	   Bambini	   et	   al.	   [39].	   fHbp	   gene	   sequences	   of	   strains	  belonging	  to	  the	  107	  MLST	  strains	  database	  [61],	  to	  the	  Swedish	  [18],	  to	  the	  England	  and	  Wales	  [5],	  and	  to	  the	  Novartis	  [39]	  collections	  were	  already	  available.	  Sequences	  were	  assembled	  and	  analysed	  using	  the	  Vector	  NTI	  Suite	  9.	  Unique	  identifiers	  were	   assigned	   to	   every	   allelic	   and	   protein	   variant	   of	   each	   protein	   and	   sequences	   were	  deposited	   into	   the	   Neisseria	   MLST	   website	   [58].	   In	   particular	   fHbp	   subvariants	   were	  designated	  as	  variant.oxford_peptide,	  NHBA	  subvariants	  were	  designated	  as	  peptide	  and	  NadA	  subvariants	  were	  designated	  as	  variant.peptide.	  
2.3.3 Data	  Analysis	  Odds	  ratio	  (OR)	  association	  statistics,	  with	  the	  support	  of	  the	  Mantel-­‐Haenszel	  test	  and	  the	  Wolf’s	   test	   for	   sample	   heterogeneity,	   were	   calculated	   as	   implemented	   by	   the	   function	  
meta.MH	   of	   the	   rmeta	   package	   of	   R	   [68].	   Fisher’s	   exact	   test	   to	   evaluate	   non-­‐random	  association	   was	   calculated	   with	   the	   function	   fisher.test	   of	   the	   stats	   package	   of	   R.	   The	  strength	  of	  the	  association	  was	  measured	  with	  the	  Cramer’s	  V	  index	  with	  R	  package	  VCD.	  Molecular	   phylogenetic	   trees	   were	   inferred	   from	   protein	   sequences	   by	   using	   the	  Maximum	  Likelihood	  (ML)	  method	  based	  on	  the	  JTT	  matrix-­‐based	  model,	  as	  implemented	  by	  MEGA5	  [28],	  after	  performing	  sequences	  alignment	  with	  muscle	  [69].	  The	  structure	  of	  cc41/44	  was	  analysed	  with	  Phyloviz	  [70]	  and	  a	  minimum	  spanning	  tree	  was	  built	  allowing	  5/7	  conserved	  MLST	  loci.	  The	  complete	  collection	  of	  isolates	  from	  the	  MLST	   database	   was	   used.	   Complex	   founder	   was	   assigned	   automatically	   to	   ST-­‐41.	   ST	  profiles	  were	  subdivided	   in	  sub-­‐complexes	  ST-­‐41,	  ST-­‐44	  and	  singlets	  on	   the	  basis	  of	   the	  diagram.	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2.4 Results	  
2.4.1 Czech	  Republic	  carriage/disease	  strain	  panel	  The	  meningococcal	  strains	   isolated	   in	  Czech	  Republic	  during	  the	  year	  1993	  and	  selected	  for	   this	   study	   were	   derived	   from	   healthy	   individuals	   or	   from	   disease	   cases.	   These	   two	  distinct	   groups	   of	   isolates	   showed	  different	   epidemiological	   traits.	   For	   example,	   isolates	  collected	   from	  healthy	   carriers	  and	   from	  disease	   cases	  were	  differently	  distributed	  with	  respect	   to	   the	   age	   groups	   of	   the	   individuals	   as	   shown	   in	   Figure	   2.1.	   	   In	   particular,	   all	  isolates	   from	   infants	   	   (0-­‐11	   months),	   young	   children	   (1-­‐4	   years),	   and	   the	   adults	   (>25	  years)	  were	  disease	  associated.	  In	  contrast,	  the	  majority	  of	  the	  isolates	  in	  the	  15-­‐24	  years	  age	   group	   were	   carriage	   associated	   and	   for	   the	   20-­‐24	   years	   age	   group	   the	  carriage/disease	   odds	   is	   significantly	   associated	   with	   carriage	   (p-­‐value	   <	   0.05,	   see	   the	  complete	  odds	  ratio	  statistics	  in	  Table	  2.1).	  	  	  	  
	  Figure	  2.1	  Epidemiology	  of	  the	  isolates:	  age	  group	  distribution,	  black	  bars	  represent	  isolates	  from	  healthy	  carriers,	  white	  bars	   represent	   isolates	   from	  disease	  cases,	   isolates	   lacking	  of	  individual	  age	  information	  are	  indicated	  by	  (NA).	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Age	  group	   carriage	   disease	   Total	   Odds	  ratio	   (95%	  CI)	   FET*	  p-­‐value	  
0-­‐11	  m	   0	   9	   9	   0.00	   0.00	  -­‐	  0.11	   3E-­‐07	  
1-­‐4	  y	   0	   19	   19	   0.00	   0.00	  -­‐	  0.04	   2E-­‐15	  
10-­‐14	  y	   0	   2	   2	   0.00	   0.00	  -­‐	  1.31	   0.039	  
15-­‐19	  y	   27	   14	   41	   0.37	   0.17	  -­‐	  0.85	   0.015	  
20-­‐24	  y	   190	   3	   193	   121	   35	  -­‐	  652	   2E-­‐31	  
25-­‐29	  y	   0	   2	   2	   0.00	   0.00	  -­‐	  1.31	   0.039	  
45-­‐49	  y	   0	   1	   1	   0.00	   0.00	  -­‐	  9.7	   0.2	  
>65	  y	   0	   1	   1	   0.00	   0.00	  -­‐	  9.7	   0.2	  
NA	   0	   2	   2	   0.00	   0.00	  -­‐	  1.31	   0.039	  
Total	   213	   53	   266	   Mantel-­‐Haenszel	  OR	  =1	   0.73	  -­‐	  1.37	  
Test	  for	  heterogeneity:	  X^2	  =	  63.5	  (p-­‐value	  0)	  	   Table	   2.1	  Age	   group	  distribution	   of	   the	   isolates,	   odds	   ratios	   and	   Fisher’s	   exact	   test	   (FET)	  statistics	  
Another	  important	  example	  is	  the	  distribution	  of	  isolates	  by	  serogroup	  and	  clonal	  complex	  as	  shown	  in	  Figure	  2.2	  and	  Table	  2.2	  respectively.	  	  Most	  serogroup	  B	  and	  C	  isolates	  were	  collected	   from	   disease	   cases	   with	   significant	   odds	   statistics	   while	   all	   non-­‐groupable	  strains	  were	  associated	  with	  carriage,	  reflecting	  the	  importance	  of	  the	  capsule	  for	  causing	  invasive	  disease	  (see	  the	  complete	  odds	  ratio	  statistics	  in	  Table	  2.3)).	  A	  relevant	  portion	  of	  non-­‐groupable	   isolates	   (72/88)	  were	   tested	   by	   sequencing	   the	   siaD	   gene,	   to	   determine	  genetically	   the	  type	  of	  capsule	  originally	  associated	  to	  the	   isolate.	   In	  21	  cases	  the	   isolate	  was	  of	  serogroup	  B,	  6	   isolates	  of	   serogroup	  C	  and	   for	   the	  remaining	  45	   isolates	  was	  not	  possible	   to	   determine	   the	   type	   by	   the	   sequencing	   of	   siaD.	   Clonal	   complexes	   ST-­‐41/44,	  cc92,	   and	   cc106	  were	   only	   associated	  with	   carriage,	  whereas	   cc11,	   cc18	   and	   cc32	  were	  selectively	  isolated	  from	  disease.	  Fifty	  out	  53	  strains	  belonging	  to	  the	  cc11	  are	  serogroup	  C	  and	  they	  have	  been	  reported	  as	  an	   important	  outbreak	   in	  Czech	  Republic	  during	  1993	  [71].	   Carriage	   associated	   strains	   belong	   to	   a	   wider	   range	   of	   clonal	   complexes	   and	   they	  appear	  more	  genetically	  variable	  than	  disease	  strains.	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  Figure	   2.2	   Serogroup	   distribution	   of	   meningococcal	   strains	   isolated	   in	   Czech	   Republic	  during	   the	   year	   1993.	   Black	   bars	   represent	   isolates	   from	   healthy	   carriers,	   white	   bars	  represent	  isolates	  from	  disease	  cases.	  
	  
Clonal	  complex	   Carriag
e	  
disease	   Total	   Odds	  
ratio	  
(95%	  CI)	   FET*	  p-­‐value	  
ST-­‐11	  complex/ET-­‐37	  
complex	   32	   20	   52	   0.29	   0.14	  -­‐	  0.61	   0.0004	  
ST-­‐41/44	  
complex/Lineage	  3	   31	   1	   32	   8.82	   1.	  4	  -­‐	  367	   0.008	  
ST-­‐92	  complex	   21	   0	   21	   Inf	   1.38	  -­‐	  	  Inf	   0.01	  
ST-­‐106	  complex	   19	   0	   19	   Inf	   1.22	  -­‐	  	  Inf	   0.02	  
ST-­‐116	  complex	   13	   0	   13	   Inf	   0.77	  -­‐	  	  Inf	   0.08	  
ST-­‐18	  complex	   5	   8	   13	   0.14	   0.033	  -­‐	  0.50	   0.0009	  
ST-­‐53	  complex	   11	   0	   11	   Inf	   0.63	  -­‐	  	  Inf	   0.13	  
ST-­‐549	  complex	   5	   0	   5	   Inf	   0.23	  -­‐	  	  Inf	   0.59	  
ST-­‐103	  complex	   4	   0	   4	   Inf	   0.16	  -­‐	  	  Inf	   0.59	  
ST-­‐231	  complex	   3	   1	   4	   0.74	   0.058	  -­‐	  40	   1	  
ST-­‐32	  complex/ET-­‐5	  
complex	   1	   3	   4	   0.08	   0.0015	  -­‐	  1.0	   0.026	  
Other	  and	  NA	   68	   20	   88	   0.77	   0.40	  -­‐	  1.5	   0.42	  
Total	   213	   53	   266	   Mantel-­‐Haenszel	  OR	  =1	   0.72	  -­‐	  1.39	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Serogroup	   carriage	   disease	   Total	   Odds	  ratio	   (95%	  CI)	   FET*	  p-­‐value	  
29E	   8	   0	   8	   Inf	   0.43	  -­‐	  Inf	   0.36	  
B	   55	   29	   84	   0.29	   0.15	  -­‐	  0.56	   0.0001	  
C	   43	   23	   66	   0.33	   0.17	  -­‐	  0.66	   0.001	  
X	   8	   0	   8	   Inf	   0.42	  -­‐	  Inf	   0.36	  
Y	   6	   1	   7	   1.50	   0.18	  -­‐	  70.6	   1	  
Z	   5	   0	   5	   Inf	   0.23	  -­‐	  Inf	   0.59	  
Non-­‐
groupable	   88	   0	   88	   Inf	   9.37	  -­‐	  Inf	   4E-­‐11	  
Total	   213	   53	   266	   Mantel-­‐Haenszel	  OR	  =1	   0.71	  -­‐	  1.41	  
Test	  for	  heterogeneity:	  X^2	  =	  27.7	  (p-­‐value	  0)	  	   Table	  2.3	  Serogroup	  distribution,	  odds	  ratios	  and	  Fisher’s	  exact	  test	  (FET)	  statistics.	  
2.4.2 Variability	  of	  fHbp,	  NadA,	  and	  NHBA	  The	   comparison	   of	   the	  molecular	   variability	   of	   fHbp,	   NadA,	   and	   NHBA	  were	   consistent	  with	   the	  results	  shown	  above.	  A	  higher	  degree	  of	  variability	  was	  observed	   in	   the	  carrier	  strain	   panel,	   as	   compared	   to	   the	   clinical	   isolates,	   particularly	   for	   fHbp.	  NadA,	  was	  more	  rarely	  present	   in	   carrier	   strains,	   as	   compared	   to	   clinical	   isolates.	   Some	  newly	  described	  STs	  were	  found	  to	  harbour	  NadA;	  however	  no	  new	  NadA	  variants	  were	  discovered.	  	  
2.4.3 fHbp	  
2.4.3.1 Distributions	  of	  variants	  and	  significant	  associations	  with	  cc	  fHbp	  was	  present	  in	  all	  isolates	  from	  Czech	  Republic,	  and	  showed	  the	  described	  structure	  in	   three	   molecular	   variants	   (fHbp-­‐1,	   fHbp-­‐2	   and	   fHbp-­‐3	   [3,	   39])	   as	   represented	   by	   the	  molecular	   phylogeny	   reconstruction	   shown	   in	   Figure	   2.3.	   In	   total,	   259/266	   genes	  were	  sequenced,	   obtaining	   32	   unique	   fHbp	   subvariants.	   Of	   these	   fHbp	   protein	   sequences,	   10	  belonged	  to	  the	  variant	  1	  (45	  isolates),	  19	  to	  variant	  2	  (211	  isolates)	  and	  3	  to	  variant	  3	  (3	  isolates).	   The	  most	   frequent	   subvariants,	   present	   in	   more	   than	   10	   isolates,	   were	   fHbp-­‐2.17,	  2.24,	  1.37,	  2.286,	  2.19,	  2.34,	  2.101	  and	  2.21.	  They	  represented	  the	  70%	  (187/266)	  of	  the	   strains.	   fHbp-­‐2.17	   and	   1.37	   predominated	   in	   disease;	   fHbp-­‐2.24	   was	   evenly	  distributed.	   Other	   subvariants	   appeared	   to	   be	   exclusively	   (fHbp-­‐2.286,	   2.34,	   2.101	   and	  2.21)	   or	   predominantly	   (fHbp-­‐2.19)	   present	   in	   carriage	   strains	   only,	   suggesting	   to	   be	  typical	  of	  carriage.	  Some	  of	  them,	  fHbp-­‐2.17,	  2.286	  and	  2.34,	  were	  also	  particularly	  rare	  in	  other	  collections	  of	  pathogenic	  isolates	  [4,	  5].	  	  Each	  fHbp	  subvariant	  seemed	  to	  be	  related	  to	   a	   specific	   clonal	   complex	   (for	   example	   fHbp-­‐2.17	   to	   cc41/44,	   fHbp-­‐2.286	   to	   cc106,	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fHbp-­‐1.37	   to	   cc18).	   In	   most	   clonal	   complexes,	   one	   of	   the	   three	   variants	   of	   fHbp	  predominated	   (A)	   (index	   of	   association	   Vfhbp	   =	   0.739).	   This	   relationship	   could	   be	  responsible	   of	   relevant	   associations	   with	   phenotypes	   or	   epidemiological	   traits	   of	   the	  clonal	   complexes,	   e.g.	   higher	   capability	   of	   inducing	   disease.	   In	   the	   Czech	   sample	  considered,	   fHbp-­‐2	   strains	   predominated	   in	   almost	   all	   clonal	   complexes;	   whereas	   cc18	  and	  cc32	  showed	  a	  significant	  proportion	  of	  fHbp-­‐1	  strains.	  Conversely,	  the	  isolates	  from	  disease	   were	   mainly	   from	   cc11,	   cc18	   and	   cc32.	   	   A	   relevant	   association	   of	   fHbp-­‐2	   with	  carriage	   was	   observed,	   whereas	   fHbp-­‐1	   was	   found	   more	   frequently	   associated	   with	  disease	  (Table	  2.4).	  This	  relationship	  could	  be	  related	  to	  the	  particular	  characteristics	  of	  the	  strain	  sample,	  which	  was	  geographically	  and	  temporally	   limited.	  Though,	   is	  worth	  of	  note	  is	  that	  similar	  observations	  were	  included	  in	  a	  carriage	  study	  performed	  by	  Harrison	  
et.	  al,	  in	  the	  United	  States	  [72].	  	  
	  	  	  	  
















































2.7 (FHBP-22) ST-698 disease
2.7 (FHBP-22) ST-698 disease
2.new251 ST-92 ST-92cc
2.9 ST-115 ST-231cc




























2.10 (FHBP-25) ST-103 ST-103cc
2.10 (FHBP-25) ST-104 ST-549cc
2.10 (FHBP-25) ST-104 ST-549cc
2.10 (FHBP-25) ST-104 ST-549cc
2.10 (FHBP-25) ST-126
2.10 (FHBP-25) ST-103 ST-103cc
2.10 (FHBP-25) ST-1004
2.10 (FHBP-25) ST-1002 ST-103cc

























3.new191 (FHBP-59) ST-740 ST-41/44cc
2.new260 ST-135
2.2 (FHBP-17) ST-116 ST-116cc
2.2 (FHBP-17) ST-116 ST-116cc
2.2 (FHBP-17) ST-116 ST-116cc
2.2 (FHBP-17) ST-116 ST-116cc
2.2 (FHBP-17) ST-116 ST-116cc
2.2 (FHBP-17) ST-116 ST-116cc
2.2 (FHBP-17) ST-116 ST-116cc
2.2 (FHBP-17) ST-116 ST-116cc
2.2 (FHBP-17) ST-116 ST-116cc
2.2 (FHBP-17) ST-116 ST-116cc
2.2 (FHBP-17) ST-116 ST-116cc
2.2 (FHBP-17) ST-116 ST-116cc
2.3 (FHBP-17) ST-11 ST-11cc
2.3 (FHBP-17) ST-11 ST-11cc
2.3 (FHBP-17) ST-11 ST-11cc
2.3 (FHBP-17) ST-11 ST-11cc
2.3 (FHBP-17) ST-11 ST-11cc disease
2.3 (FHBP-17) ST-11 ST-11cc
2.3 (FHBP-17) ST-11 ST-11cc
2.3 (FHBP-17) ST-11 ST-11cc disease
2.3 (FHBP-17) ST-11 ST-11cc
2.3 (FHBP-17) ST-11 ST-11cc
2.3 (FHBP-17) ST-11 ST-11cc
2.3 (FHBP-17) ST-11 ST-11cc disease
2.3 (FHBP-17) ST-11 ST-11cc
2.3 (FHBP-17) ST-11 ST-11cc disease
2.3 (FHBP-17) ST-11 ST-11cc
2.3 (FHBP-17) ST-11 ST-11cc disease
2.3 (FHBP-17) ST-11 ST-11cc disease
2.3 (FHBP-17) ST-11 ST-11cc disease
2.3 (FHBP-17) ST-11 ST-11cc disease
2.3 (FHBP-17) ST-672 ST-11cc
2.3 (FHBP-17) ST-11 ST-11cc disease
2.3 (FHBP-17) ST-11 ST-11cc
2.3 (FHBP-17) ST-11 ST-11cc disease
2.3 (FHBP-17) ST-11 ST-11cc
2.3 (FHBP-17) ST-11 ST-11cc
2.3 (FHBP-17) ST-11 ST-11cc
2.3 (FHBP-17) ST-11 ST-11cc disease
2.3 (FHBP-17) ST-11 ST-11cc
2.3 (FHBP-17) ST-11 ST-11cc
2.3 (FHBP-17) ST-11 ST-11cc disease
2.3 (FHBP-17) ST-11 ST-11cc disease
2.3 (FHBP-17) ST-11 ST-11cc disease
2.3 (FHBP-17) ST-11 ST-11cc
2.3 (FHBP-17) ST-11 ST-11cc disease
2.3 (FHBP-17) ST-11 ST-11cc
2.3 (FHBP-17) ST-11 ST-11cc
2.3 (FHBP-17) ST-11 ST-11cc
2.3 (FHBP-17) ST-11 ST-11cc
2.3 (FHBP-17) ST-11 ST-11cc disease
2.3 (FHBP-17) ST-11 ST-11cc disease
2.3 (FHBP-17) ST-11 ST-11cc disease
2.3 (FHBP-17) ST-11 ST-11cc
2.3 (FHBP-17) ST-11 ST-11cc
2.3 (FHBP-17) ST-11 ST-11cc disease
2.3 (FHBP-17) ST-11 ST-11cc
2.3 (FHBP-17) ST-11 ST-11cc
2.3 (FHBP-17) ST-733 ST-11cc
2.3 (FHBP-17) ST-11 ST-11cc disease
2.3 (FHBP-17) ST-11 ST-11cc
2.3 (FHBP-17) ST-11 ST-11cc
2.3 (FHBP-17) ST-11 ST-11cc
2.1 (FHBP-16) ST-989 ST-18cc
2.1 (FHBP-16) ST-114 ST-22cc
2.1 (FHBP-16) ST-113 ST-22cc
2.1 (FHBP-16) ST-114 ST-22cc
2.1 (FHBP-16) ST-1000 ST-35cc













2.4 (FHBP-19) ST-718 disease
2.4 (FHBP-19) ST-101
2.4 (FHBP-19) ST-112 ST-41/44cc
2.4 (FHBP-19) ST-110 ST-41/44cc
2.4 (FHBP-19) ST-110 ST-41/44cc
2.4 (FHBP-19) ST-110 ST-41/44cc
2.4 (FHBP-19) ST-110 ST-41/44cc
2.4 (FHBP-19) ST-110 ST-41/44cc
2.4 (FHBP-19) ST-110 ST-41/44cc









1.new278 ST-118 ST-32cc disease
1.new248 ST-87
1.new248 ST-82 ST-254cc
1.new290 ST-994 ST-292cc disease







1.1 (FHBP-1) ST-118 ST-32cc disease
1.new296 ST-118 ST-32cc











1.new209 ST-1001 ST-18cc disease
1.new209 ST-988 ST-18cc disease
1.new209 ST-18 ST-18cc disease
1.new209 ST-18 ST-18cc
1.new209 ST-720 ST-18cc disease
1.new209 ST-737 ST-18cc disease
1.new209 ST-145 ST-18cc disease
1.new440 ST-145 ST-18cc disease
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   Figure	  2.3	  Molecular	  phylogeny	  of	  fHbp.	  Molecular	  evolutionary	  relationships	  were	  inferred	  using	   the	  Maximum	  Likelihood	  method.	   The	   evolutionary	  distances	  were	   computed	  using	  the	  JTT	  matrix-­‐based	  method	  and	  the	  units	  are	  number	  of	  amino	  acid	  substitutions	  per	  site.	  The	  9	  most	  represented	  clonal	  complexes	  were	  coloured	  (cc11,	  cc41/44,	  cc92,	  cc106,	  cc116,	  cc18,	   cc53,	   cc549,	   cc32).	   All	   protein	   subvariants-­‐peptides	   are	   strongly	   associated	   with	  clonal	  complexes.	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Figure	  2.4	  Vaccine	  antigens	  distribution	  among	  clonal	  complexes.	  Each	  protein	  subvariant	  /	  peptide	  was	  represented	  for	  both	  fHbp	  (A)	  and	  NHBA	  (B).	  The	  presence	  or	  absence	  of	  the	  gene	  was	  considered	  for	  NadA	  (C),	  a	  special	  case	  is	  the	  gene	  interrupted	  by	  IS1301,	  typical	  of	  cc11.	  
	  
fHbp	  
variant	   carriage	   disease	   Total	   Odds	  ratio	   (95%	  CI)	   FET*	  p-­‐value	  
1	   29	   17	   46	   0.33	   0.16	  -­‐	  0.72	   0.003	  
2	   179	   32	   211	   3.43	   1.67	  –	  7.01	   0.0004	  
3	   1	   3	   4	   0.08	   0.00	  -­‐	  1.00	   0.025	  
ND	   4	   1	   5	   0.99	   0.09	  –	  49.9	   1	  
Total	   213	   53	   266	   Mantel-­‐Haenszel	  OR	  =1	   0.66	  -­‐	  1.52	  
Test	  for	  heterogeneity:	  X^2	  =	  29.5	  (p-­‐value	  0)	  	   Table	  2.4	  Odds	  ratios	  representing	  the	  association	  of	  fHbp	  variants	  (1,	  2	  or	  3)	  to	  carriage	  or	  disease.	  
2.4.3.2 Global	  distribution	  of	  fHbp	  variants	  within	  cc41/44	  The	  expansion	  of	  clones	  originating	  from	  a	  common	  ancestor	  can	  be	  traced	  by	  observing	  the	   strain	   similarity	  of	  MLST	  allelic	  profiles	   and	   the	  positioning	  of	   clones	   in	   a	  minimum	  spanning	   tree	   diagram	   performed	   for	   example	   with	   the	   goeBURST	   algorithm	   [70].	   The	  clonal	   complex	   ST-­‐41/44	   is	   known	   to	  be	   structured	   in	   two	  main	   sub-­‐complexes	   (ST-­‐41,	  ST-­‐44),	   and	  with	   the	   help	   of	   the	   goeBURST	   cc41/44	   diagram,	   isolates	  were	   assigned	   in	  three	  sub-­‐groups	  (Figure	  2.5):	  ST-­‐41,	  ST-­‐44	  and	  Singlets.	  To	  perform	  this	  assignment,	  data	  of	   2492	   cc41/44	   isolates	   retrieved	   from	   MLST	   database	   were	   analyzed.	   The	   disease	  outcome	   of	   the	   2492	   isolates	   reported	   from	  MLST	   database	   was	   peculiarly	   distributed	  (see	  Figure	  2.6):	  59%	  were	  from	  invasive	  cases,	  31%	  from	  healthy	  carriers	  and	  12%	  from	  other	   of	   uncharacterized	   cases.	   The	   percentages	   appeared	   different	  when	  we	   looked	   at	  sub-­‐complexes.	   In	   fact,	   ST-­‐41	   sub-­‐complex	  was	  mainly	   associated	  with	   invasive	   disease	  events	  (72%	  of	  ST-­‐41	  strains	  sub-­‐complex	  are	  from	  disease),	  whereas	  ST-­‐44	  sub-­‐complex	  included	  a	  relevant	  proportion	  of	  strains	  associated	  with	  carriage	  (45%	  of	  strains	  of	  this	  sub-­‐complex	  are	  from	  carriers).	  In	  particular	  the	  59%	  of	  carriage	  strains,	  belonged	  to	  the	  ST-­‐44	  sub	  complex.	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To	  have	  a	  more	  complete	  picture	  of	  the	  fHbp	  variant	  distribution	  within	  cc41/44,	  and	  to	  assess	   any	   correlation	   with	   pathogenic	   or	   carriage	   strains,	   we	   expanded	   the	   results	  obtained	   in	   the	  Czech	  strain	  panel,	  with	   the	  results	  obtained	   from	  other	  epidemiological	  studies	   where	   fHbp	   was	   sequenced.	   In	   total,	   255	   cc41/44	   isolates	   were	   analysed.	   We	  compared	  the	  clonal	  complex	  distribution	  and	  disease	  outcome	  of	   the	  255	  isolates	  panel	  against	  the	  data	  of	  2492	  cc41/44	  isolates	  collected	  from	  the	  entire	  MLST	  database.	  In	  the	  255	  isolates	  panel,	  the	  ST-­‐41	  sub-­‐complex	  (192	  isolates)	  included	  a	  predominance	  (97%)	  of	  strains	  associated	  with	  disease.	  Conversely,	  the	  ST-­‐44	  sub	  complex	  (51	  isolates)	  included	   a	   relevant	   fraction	   (53%)	   of	   carriage	   associated	   strains.	   And	   the	   79%	   of	   all	  carriage	  isolates,	  within	  the	  255,	  belong	  to	  the	  ST-­‐44	  sub	  complex.	  In	  particular	  looking	  at	  the	   32	   Czech	   carriage	   clones,	   31	   are	   distributed	   into	   the	   sub-­‐complex	   expanded	   from	  clone	  ST-­‐44.	  The	  only	  strain	  causing	  disease	  belongs	  to	  the	  sub-­‐complex	  ST-­‐41.	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  Figure	   2.6	   cc41/44	   isolates	   and	   carriage/disease	   outcome	   distribution	   within	   the	   255	  isolates	  panel	  (a)	  and	  the	  2492	  isolates	  from	  MLST	  database	  (b).	  Blu	  bars	  represent	  isolates	  collected	   from	   disease	   cases,	   red	   represent	   isolates	   collected	   from	   healthy	   carriers	   and	  green	  undefined	  isolates.	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carriage/disease	  were	  32/20.	  Other	  carriage	  associated	  clonal	   complexes	  were	  cc92	  (21	  isolates,	  8	  different	  ST).	  Predominant	  cc92	  ST	  was	  the	  one	  central	  to	  the	  clonal	  complex,	  namely	   ST-­‐92	   (13	   isolates).	   Cc92	   strains	   had	   predominantly	   fHbp-­‐2.101	   and	   fHbp-­‐2.21.	  Else,	  cc106	  again	  was	  more	  homogenous,	  19/19	  cc106	  isolates	  (16/19	  ST-­‐106)	  harboured	  fHbp-­‐2.286.	   12/13	   cc116	   isolates	   (12/13	   ST-­‐116)	   harboured	   fHbp-­‐2.17.	   The	   disease	  associated	  clonal	  complex	  ST-­‐18	  was	  more	  variable	  in	  terms	  of	  sequence	  types	  (9	  STs	  out	  of	  13	  isolates).	  Conversely,	  11/13	  isolates	  harboured	  fHbp-­‐1.37,	   indicating	  a	  quite	  stable	  fHbp	  genotype	  in	  this	  clonal	  complex.	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2.4.4 NHBA	  
2.4.4.1 Distributions	   of	   variants	   and	   significant	   associations	   with	   clonal	   complexes	   and	  
carriage	  The	   neisserial	   heparin	   binding	   antigen	   was	   present	   in	   all	   strains	   tested	   (261/266)	  showing	  44	  different	  peptides.	  8	  NHBA	  peptides	  were	  present	  in	  a	  minimum	  of	  10	  strains,	  NHBA-­‐20,	  2,	  9,	  55,	  24,	  53,	  54	  and	  58).	  Altogether,	  they	  represent	  the	  69%	  of	  the	  isolates	  (179/261).	   The	   number	   of	   protein	   forms	   was	   higher	   than	   fHbp.	   Conversely,	   variability	  within	   clonal	   complexes	   is	   lower,	   and	   the	   clonal	   distribution	   is	   comparable	   (index	   of	  association	  VNHBA	  =	  0.732).	  In	  fact	  the	  phylogenetic	  reconstruction	  shown	  in	  Figure	  2.8	  and	  the	   bar	   plot	   distribution	   shown	   in	   B	   clearly	   identify	   clades	   and	   specific	   protein	   forms	  mostly	   dedicated	   to	   a	   single	   clonal	   complex	   and	   related	   to	   carriage	   isolates	   only.	   Some	  examples	   of	   association	   were:	   NHBA-­‐2	   and	   cc41/44;	   NHBA-­‐9	   and	   cc92,	   NHBA-­‐55	   and	  cc106	  both	  with	  a	  significant	  proportion	  of	  carriage	  isolates;	  NHBA-­‐53	  and	  cc116,	  NHBA-­‐58	  and	  cc53.	  NHBA-­‐20	  was	  predominantly	  present	  in	  cc11,	  though	  it	  was	  also	  shared	  with	  other	   complexes	  and	   it	   shows	  a	   significant	  proportion	  of	  disease	   isolates.	  NHBA-­‐54	  was	  typical	   of	   cc18	   strains,	  NHBA-­‐24	  was	   equally	  distributed	   in	   cc103	  and	   cc549	   strains,	   all	  strains	  isolated	  from	  carriage.	  The	  summary	  of	  the	  most	  frequent	  NHBA	  peptides	  and	  how	  it	  is	  distributed	  with	  respect	  to	  healthy	  carriers	  or	  disease	  cases	  is	  shown	  in	  Table	  2.5.	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carriage	   disease	   Total	   Odds	  
ratio	  
(95%	  CI)	   FET*	  p-­‐
value	  
20	   41	   22	   63	   0.33	   0.17	  -­‐	  0.66	   0.001	  
2	   28	   3	   31	   2.46	   0.72	  -­‐	  13.17	   0.16	  
9	   22	   0	   22	   Inf	   1.43	  -­‐	  Inf	   0.01	  
55	   17	   0	   17	   Inf	   1.05	  -­‐	  Inf	   0.03	  
24	   13	   0	   13	   Inf	   0.76	  -­‐	  Inf	   0.08	  
53	   13	   0	   13	   Inf	   0.76	  -­‐	  Inf	   0.08	  
54	   8	   2	   10	   0.98	   0.19	  -­‐	  9.71	   1	  
58	   10	   0	   10	   Inf	   0.55	  -­‐	  Inf	   0.22	  	   Table	   2.5	   Odds	   ratios	   representing	   the	   association	   of	   most	   frequent	   NHBA	   peptide	  sequences	  with	  carriage	  or	  disease.	  	  
2.4.5 NadA	  	  
2.4.5.1 Presence	  /	  absence	  and	  variants	  The	  nadA	   gene	  was	  present	   in	  79	  out	  of	  266	  Czech	   isolates	   (30%).	  With	   respect	   to	  data	  reported	   on	   our	   previous	   studies,	   in	   addition	   to	   serogroup	   B	   and	   C,	   also	   serogroup	   X	  isolates	  and	  some	  newly	  assigned	  STs	  were	  found	  to	  harbour	  nadA	  gene.	  Actually,	  the	  gene	  was	   present	   in	   23	   out	   of	   79	   positive	   isolates	   (29%)	   as	   an	   integer	   gene.	   nadA	   positive	  strains	   belonged	   to	   cc32	   (4	   isolates),	   cc18	   (2	   isolates)	   and	   to	   12	   different	   STs	   did	   not	  belonging	   to	   already	   assigned	   clonal	   complexes	   (17	   isolates)	   (C).	   Sequence	   analyses	  revealed	   that	   in	   56	   (71%)	   isolates	   the	   gene	  was	   interrupted	   by	   the	   insertion	   sequence	  
IS1301.	  52	  out	  56	  isolates	  showing	  an	  interrupted	  nadA	  gene	  belonged	  to	  the	  cc11,	  mostly	  to	  the	  serogroup	  C	  outbreak	  The	  association	  of	  nadA	  gene	  interrupted	  by	  IS1301	  and	  cc11	  strains,	   in	  particular	  belonging	  to	  the	  ET-­‐15	  clone,	  was	  described	  by	  Elias	  et	  al.	  [73].	  The	  clonal	   complex	   assignment	   is	   a	   good	  descriptor	   of	   the	  NadA	  presence	   due	   to	   a	   relevant	  association	  (VnadA	  =	  0.71).	  Five	  NadA	  variants	  were	  found,	  both	  in	  invasive	  than	  in	  carrier	  isolates	  (C):	  NadA-­‐1	  and	  NadA-­‐3,	  which	  we	  described	  as	  mainly	  associated	  with	  invasive	  isolates	  [21],	  NadA-­‐4,	  mainly	  associated	  with	  carriage	  [22],	  NadA-­‐5,	  which	  was	  described	  
	  	  	  	  
61	  
to	   be	   associated	   with	   cc213	   and	   a	   NadA-­‐4/NadA-­‐5	   related	   variant	   first	   described	   by	  Lucidarme	  and	  colleagues	  [13].	  	  
2.4.5.2 Differences	  between	  carriage	  and	  disease	  In	  the	  Czech	  strain	  panel,	  the	  presence	  of	  the	  nadA	  gene	  was	  differently	  distributed	  when	  we	   consider	   strains	   isolated	   from	  healthy	   carriers	   and	  disease	   isolates.	  nadA	  was	   rarely	  present	  in	  carrier	  strains	  (37%),	  as	  compared	  with	  clinical	   isolates	  (63%)	  (Table	  2.6).	  In	  particular,	  nadA	   negative	   strains	  had	  a	   relevant	  proportion	  of	   strains	   from	  carriage	   (OR	  3.45,	  p-­‐value	  0.0001).	   Instead,	  nadA	  positive	  isolates	  were	  associated	  with	  disease	  (OR	  =	  0.32,	   p-­‐value	   0.05).	   These	   observations	   are	   in	   agreement	   with	   the	   role	   of	   NadA	   in	   the	  adhesion	   and	   pathogenicity	   of	  Nm.	   NadA-­‐1	   and	  NadA-­‐3	   variants	  were	  more	   frequent	   in	  disease	  isolates;	  on	  the	  contrary,	  NadA-­‐4,	  NadA-­‐5	  and	  NadA4\NadA-­‐5	  variants	  were	  more	  frequent	  in	  carrier	  isolates	  and	  showed	  a	  higher	  degree	  of	  sequence	  variability.	  	  
NadA	  
presence	   carriage	   disease	   Total	   Odds	  Ratio	   (95%	  CI)	   FET*	  p-­‐value	  
-­‐	   164	   25	   189	   3.45	   1.77	  -­‐	  6.76	   0.0001	  
+	   10	   7	   17	   0.32	   0.10	  -­‐	  1.04	   0.05	  
IS	   39	   21	   60	   0.34	   0.17	  -­‐	  0.68	   0.001	  
IS	  and	  -­‐	   203	   46	   249	   2.20	   0.71	  -­‐	  6.23	   0.15	  
Total	   217	   53	   266	   Mantel-­‐Haenszel	  OR	  =1	   0.76	  -­‐	  1.54	  
Test	  for	  heterogeneity:	  X^2	  =	  33.7	  (p-­‐value	  0)	  	   Table	  2.6	  	  Odds	  ratios	  representing	  the	  association	  of	  nada	  gene	  presence	  (+),	  absence	  (-­‐)	  or	  interrupted	  locus	  (IS)	  to	  carriage	  or	  disease.	  
2.4.6 Variability	  of	  PorA	  and	  FetA	  variable	  regions	  Interestingly,	   the	   distribution	   of	   the	   variable	   regions	   of	   the	   surface	   proteins	   PorA	   and	  FetA,	  was	  similar	  to	  the	  previously	  described	  surface	  proteins.	  In	  fact,	  despite	  the	  fact	  that	  variable	  epitopes	  of	  the	  proteins	  are	  significantly	  more	  spread,	  showing	  a	  higher	  number	  of	   variants	   (20	   for	   PorA_VR1,	   42	   for	   PorA_VR2	   and	   38	   for	   FetA_VR),	   they	   resulted	  comparably	  associated	  to	  the	  clonal	  complexes	  (index	  of	  association	  are	  VPorA_VR1	  =	  0.503,	  VPorA_VR2	  =	  0.675	  and	   	  VfetA_VR	  =	  0.711).	  Due	   to	   the	  high	  number	  of	  peptides	  observed	  and	  consequent	  small	  respective	  frequencies,	  only	  few	  variants	  have	  a	  significant	  OR	  statistics	  with	  respect	  to	  carriage	  or	  disease.	  The	  most	  relevant	  PorA	  subtype	  associated	  to	  carriage	  is	  PorA	  P1.5-­‐1	  (typical	  of	  cc106	  and	  cc92,	  and	  of	  other	  complexes,	  as	  well).	  Subtype	  P1.5,2	  with	  FetA3-­‐6,	  which	  were	  typical	  of	  cc11	  isolates,	  and	  P1.7,16	  with	  FetA3-­‐3,	  which	  were	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all	   typical	   of	   cc32	   isolates,	   showed	   	   relevant	   odds	   ratio	   statistics	   of	   association	   with	  disease	  cases.	  
2.5 Discussion	  and	  conclusions	  The	   genetic	   variability	   of	   a	   panel	   of	   meningococcal	   isolates	   collected	   in	   Czech	  Republic	   during	   the	   year	   1993	   was	   studied	   with	   a	   particular	   focus	   on	   the	   differences	  between	   isolates	   collected	   from	   healthy	   carriers	   and	   isolates	   collected	   from	   people	  affected	   by	   disease.	   The	   distribution	   and	   prevalence	   of	   specific	   surface	   proteins,	   fHbp,	  NadA	  and	  NHBA,	  main	  components	  of	   the	  4CMenB	  (Bexsero®)	  vaccine	  against	  Nm,	  were	  studied	   in	   function	   of	   different	   genetic	   characters	   of	   the	  meningococcal	   isolates.	   Clonal	  complex	   grouping	   was	   the	   major	   descriptor	   of	   the	   antigens	   variability	   because	   of	   the	  already	   described	   association	   between	  molecular	   variants	   and	   clonal	   complexes.	   For	   all	  the	   surface	   proteins	   evaluated,	   the	   distribution	   of	   variants	   was	   strongly	   related	   to	   the	  genetic	   characteristics	  of	   the	   strains.	  Also,	  odds	   ratios	  deviations	  demonstrated	   relevant	  relationships	   of	   protein	   diversity	   with	   carriage,	   or	   with	   disease.	   fHbp-­‐2	   was	   strongly	  associated	   with	   strains	   derived	   from	   healthy	   carriers,	   with	   fHbp-­‐2.17	   and	   fHbp-­‐2.24	  predominating,	  whereas	   fHbp-­‐1	   and	   fHbp-­‐3	  were	  more	   strongly	   associated	  with	   strains	  derived	   from	   disease	   cases.	   The	   higher	   frequency	   of	   fHbp-­‐1	   in	   invasive	   isolates	   was	   in	  agreement	  also	  with	  data	  obtained	  in	  recent	  studies	  in	  Europe	  [5]	  and	  United	  States	  [74].	  The	   nadA	   gene	   was	   only	   present	   in	   a	   subset	   of	   isolates.	   It	   was	   prevalent	   and	   more	  conserved	   in	  disease	   isolates,	  whereas	   it	  was	   less	   frequent	   and	  more	  variable	   in	   carrier	  isolates.	  Finally,	  NHBA	  protein	  was	  always	  present	   in	   the	   tested	   isolates,	   it	  was	  strongly	  associated	   to	   the	   clonal	   complexes	   and	   some	   specific	   protein	   forms	   were	   related	   to	  carriage	  only.	  NHBA-­‐20	  was	  the	  most	  frequent	  both	  in	  carriage	  than	  in	  disease	  isolates	  in	  the	   present	   strain	   panel.	   On	   the	   contrary,	   in	   more	   recent	   (2007-­‐2008)	   invasive	   strain	  collections	  in	  Europe,	  NHBA-­‐2	  was	  predominant	  [5].	  Molecular	  phylogeny	  was	  reconstructed	  for	  fHbp	  and	  NHBA	  proteins,	  showing	  that	  clonal	  complex	  grouping	  strongly	  correlates	  to	  specific	  tree	  clades.	  Rarely	  the	  fHbp	  subvariants	  and	   the	   NHBA	   peptides,	   which	   are	   typical	   of	   a	   clonal	   complex,	   are	   found	   in	   other	  complexes.	  This	  would	  indicate	  a	   limited	  rate	  of	  recombination	  between	  complexes	  after	  their	   diversification.	   Interesting	   differences	   in	   the	   antigenic	   repertoires	   of	   carriage	   and	  pathogenic	   strains	   belonging	   to	   the	   same	   clonal	   complex	   were	   found.	   NHBA	   protein	  showed	  a	  high	  level	  of	  clonality,	  in	  particular	  a	  high	  association	  index	  with	  clonal	  complex	  designation.	   The	   analysis	   of	   the	   fHbp	   structuring	   within	   cc41/44	  was	   investigated	   in	   a	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collection	  of	  255	  carriage	  and	  disease	   isolates,	  by	  comparison	  of	  protein	  sequences.	  The	  analysis	  demonstrated	   that	   fHbp	  variants	  and	  subvariants	  are	  non-­‐randomly	  distributed	  in	   ST-­‐41/44	   sub-­‐complexes.	   fHbp-­‐1	   subvariants	   are	   mostly	   associated	   with	   cc41/44	  isolates	   collected	   from	   disease	   cases,	   which	   are	   preferentially	   included	   into	   	   the	   ST-­‐41	  sub-­‐complex.	  	  Instead,	  fHbp-­‐2	  subvariants	  are	  mostly	  associated	  with	  carriage	  strains.	  The	  majority	  of	  strains	  from	  healthy	  carriers	  belong	  to	  ST-­‐44	  sub-­‐complex.	  	  This	   study	   was	   conducted	   using	   a	   well-­‐recognized	   strain	   panel	   for	   studies	   on	  meningococcal	  carriage.	  	  It	  was	  optimal	  for	  a	  comparison	  between	  diversity	  on	  carriage	  vs	  diversity	   in	   disease	   strains,	   because	   pathogenic	   strains	   occurred	   in	   the	   same	   area,	   and	  during	   the	   same	   epidemiological	   year	   of	   isolation,	   were	   included	   in	   the	   same	   sample.	  These	   findings	  are	   important	   for	   vaccine	  development,	   in	  particular	  once	  evaluating	   the	  vaccine	  effectiveness	  and	  protection	  against	  both	  disease-­‐causing	  and	  carriage	  strains.	  In	  fact,	   the	  distribution	  of	   the	  4CMenB	  vaccine	  antigens	   in	   the	  meningococcal	   isolates	   from	  healthy	   individuals,	   suggests	   that	   vaccination	   could	   have	   an	   impact	   on	   carriage	   and	  suggests	  that	  the	  determination	  of	  the	  vaccine	  coverage	  on	  carriage	  would	  be	  of	  complex	  estimation	  as	   in	  disease-­‐causing	  isolates	  of	  serogroup	  B	  [5].	  However,	  as	  recently	  shown	  for	   the	  4CMenB	  vaccine	   [75],	   the	  ability	  of	  vaccine-­‐induced	  antibodies	   to	  mediate	  killing	  depends	  on	  their	  ability	   to	  react	  with	  the	  antigen	  variant/peptide	  present	   in	  the	  vaccine	  and	  on	  the	  amount	  of	  antigen	  expressed	  by	  a	  given	  strain	  that	  can	  vary	  in	  response	  of	  yet	  uncharacterized	   environmental	   factors,	   as	   recently	   demonstrated	   for	   NadA	   [76].	  Therefore,	  only	  typing	  methods	  taking	  into	  account	  this	  aspects	  would	  strain	  coverage	  and	  further	   studies	  will	  be	  needed	   to	  evaluate	  whether	   this	  vaccine	  will	  have	  any	   impact	  on	  meningococcal	  carriage.	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Chapter	  3. An	   analysis	   of	   the	   sequence	   variability	   of	  
meningococcal	  fHbp,	  NadA	  and	  NHBA	  over	  a	  50-­‐year	  period	  
in	  the	  Netherlands.	  
3.1 Abstract	  Studies	  of	  meningococcal	  evolution	  and	  genetic	  population	  structure,	   including	  the	  long-­‐term	  stability	  of	  non-­‐random	  associations	  between	  variants	  of	  surface	  proteins,	  are	  essential	   to	   evaluate	   the	   effect	   of	   a	   vaccine.	   In	   this	   work	   we	   analysed	   the	   sequence	  variability	  of	  factor	  H-­‐binding	  protein	  (fHbp),	  Neisserial	  Heparin-­‐Binding	  Antigen	  (NHBA)	  and	  Neisseria	  adhesin	  A	  (NadA),	  in	  a	  panel	  of	  invasive	  isolates	  collected	  in	  the	  Netherlands	  over	  a	  period	  of	  50	  years.	  To	  our	  knowledge,	  this	  strain	  collection	  covers	  the	  longest	  time	  period	   of	   any	   collection	   available	   worldwide.	   Long-­‐term	   persistence	   of	   several	   antigen	  sub/variants	  and	  of	  non-­‐overlapping	  antigen	  sub/variant	  combinations	  was	  observed.	  Our	  data	   suggest	   that	   certain	   antigen	   sub/variants	   including	   those	   used	   in	   4CMenB	   are	  conserved	  over	  time	  and	  promoted	  by	  selection.	  
3.2 Introduction	  
N.	   meningitidis	   bacterial	   population	   is	   structured	   in	   highly	   diverse	   lineages	   that	  show	   patterns	   of	   an	   extensive	   genetic	   exchange	   [77].	   Studies	   of	   genetic	   variation,	   by	  MultiLocus	   Enzyme	   Electrophoresis	   (MLEE)	   [78]	   and	   subsequently	   by	   MultiLocus	  Sequence	   Typing	   (MLST)	   [58],	   showed	   that	   meningococci	   are	   structured	   in	   lineages	  defined	   as	   ‘clonal	   complexes’	   [79,	   80],	   some	   of	   which	   are	   clearly	   associated	   to	   the	  capability	   to	   cause	   invasive	   disease	   and	   for	   this	   reason	  were	   defined	   as	   ‘hypervirulent’	  clonal	  complexes	  [81].	  	  Strains	  belonging	  to	  the	  hypervirulent	  clonal	  complexes	  are	  over-­‐represented	   in	   collections	   of	   pathogenic	   isolates.	   Clonal	   complexes	   are	   relatively	  genetically	  stable	  over	  time,	  despite	  high	  rates	  of	  recombination	  [58].	  	  The	  persistence	  of	  clonal	  complex	  structure	  despite	  high	  levels	  of	  recombination	  can	  be	   explained	   by	   evolutionary	  models	   that	   invoke	   positive	   selection	   [65,	   66],	   which	   has	  important	   implications	   for	   the	  design	  of	  protein-­‐based	  vaccines	  against	  meningococci	  of	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serogroup	   B	   (MenB).	   In	   fact,	   outer	   membrane	   vesicle	   (OMV)	   vaccines	   that	   rely	   on	   the	  immunogenic	   properties	   of	   PorA	   [82-­‐85],	   have	   been	   used:	   though,	   those	   vaccines	   only	  provide	   protection	   for	   homologous	   strains	   carrying	   the	   same	   PorA	   [86].	   To	   overcome	  antigenic	   variability,	   vaccines	   based	   on	   multiple	   outer	   membrane	   proteins	   have	   been	  proposed	   to	   provide	   protection	   against	   a	   broad	   range	   of	   meningococcal	   isolates.	   Novel	  antigens	   were	   identified	   by	   Reverse	   Vaccinology	   [16,	   86,	   87]	   and	   combined	   into	   a	  multicomponent	   vaccine	   against	   MenB,	   4CMenB	   (Bexsero®).	   4CMenB	   includes	   OMVs	  from	   the	   New	   Zealand	   MeNZB®	   vaccine	   and	   three	   major	   protein	   antigens:	   factor	   H-­‐binding	  protein	  (fHbp),	  Neisserial	  Heparin-­‐Binding	  Antigen	  (NHBA)	  and	  Neisseria	  adhesin	  A	  (NadA).	  Statistical	   association	   studies	   indicate	   that	   the	   repertoire	   of	   fHbp,	   NHBA	   and	   NadA	   is	  structured	  among	  hyperinvasive	   lineages.	   Isolates	   from	   the	   same	  clonal	   complexes	  have	  similar	  profiles	  for	  each	  antigen,	  even	  when	  derived	  from	  disparate	  geographical	  locations	  and	  time	  periods	  [39].	  We	   investigated	   the	   prevalence	   and	   sequence	   variation	   of	   fHbp,	   NHBA	   and	   NadA	   in	   a	  panel	  of	  165	  pathogenic	  meningococcal	  isolates	  randomly	  selected	  from	  those	  collected	  in	  the	  Netherlands	  over	  a	  period	  of	  50	  years.	  
3.3 Methods	  
3.3.1 Bacterial	  isolates	  One	  hundred	  sixty-­‐five	  meningococcal	  isolates	  collected	  from	  clinical	  cases	  (from	  blood	  or	  cerebrospinal	   fluid)	   in	   the	   Netherlands	   were	   randomly	   selected	   at	   the	   Netherlands	  Reference	  Laboratory	   for	  Bacterial	  Meningitis	   (NRLBM).	  Approximately	  30	   isolates	  were	  included	  from	  each	  decade	  as	   follows:	  every	  2nd,	  5th,	  10th,	  20th,	  20th	  and	  10th	   isolate	  were	  chosen	  of	  the	  years	  1960,	  1970,	  1980,	  1990,	  2000	  and	  2008-­‐2009,	  respectively.	  Upon	   receipt	   of	   bacterial	   isolates	   in	   the	   NRLBM,	   a	  monoculture	   of	   the	   causative	   isolate	  was	  frozen	  and	  stored	  at	  –80°C.	  All	  isolates	  were	  passaged	  fewer	  than	  5	  times.	  All	  isolates	  were	   characterized	  by	   serogroup,	   and	   sequencing	  of	   PorA,	   FetA,	   fHbp,	  NHBA,	  NadA	  and	  MLST	  [67,	  80,	  88].	  Discrimination	   between	   ST44	   and	   ST41	   subcomplexes	   of	   clonal	   complex41/44	   was	  assessed	  by	  PCRs	  targeting	  MoxR	  like	  AAA	  ATPase	  and	  nmeSI,	  respectively	  [89,	  90].	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3.3.2 Sequence	  analysis	  and	  measure	  of	  the	  associations	  between	  different	  loci	  DNA	  sequences	  were	  assembled	  and	  analysed	  using	  Sequencher	  version	  4.10.1	  sequence	  analysis	   software	   (Gene	   Codes	   Corporation,	   Ann	  Arbor,	  MI	  USA),	   BioEdit	   (developed	   by	  Tom	   Hall,	   Ibis	   Biosciences),	   Molecular	   Evolutionary	   Genetics	   Analysis	   (MEGA)	   software	  version	  4.0	  [91]	  and	  Jalview	  [92].	  Molecular	   typing	   of	   fHbp,	   NHBA	   and	   NadA	   sub/variants	   was	   based	   on	   amino	   acid	  sequence	   determination.	   fHbp	   sub/variants	   were	   designated	   as	   variants.oxford.peptide	  (http://pubmlst.org/neisseria/fHbp/).	   NHBA	   sub/variants	   were	   designated	   as	   peptides.	  NadA	  sub/variants	  were	  designated	  as	  variant.peptide.	  The	   structure	   of	  MLST	   clonal	   complexes	  was	   analysed	  with	  PHYLOViZ	  1.0	   based	   on	   the	  goeBURST	  algorithm	  [70].	  The	   Cramer’s	   V	   coefficient	   [93]	   was	   used	   to	   measure	   association	   statistics	   with	   clonal	  complexes.	  The	  Standardized	  Index	  of	  Association	  IAS	  [94]	  was	  used	  to	  test	  the	  stability	  of	  associations	   between	   different	   loci.	   The	   non-­‐overlapping	   structure	   of	   antigen	   variant	  combinations	  was	  measured	  by	  f*	  metrics	  [66].	  The	  three	  statistical	  parameters	  V,	  IAS	  and	  
f*	  are	  based	  on	  the	  frequency	  of	  the	  alleles	  and	  vary	  between	  0	  (random	  distribution)	  and	  1	  (perfect	  association	  or	  non	  overlapping	  distribution	  in	  the	  case	  of	  f*).	  
3.4 Results	  
3.4.1 Prevalence	   and	   Distribution	   of	   Sequence	   Types	   (STs)	   and	   MLST	   Clonal	   Complexes	  
Over	  Time	  Ninety-­‐five	  different	  STs	  and	  22	  clonal	  complexes	  were	  found.	  In	  detail,	  ST-­‐8	  (9%),	  ST-­‐11	  (8%),	  ST-­‐41	  (8%),	  ST-­‐1	  (5%)	  were	  the	  most	  commonly	  represented	  STs.	  ST-­‐1,	  ST-­‐41	  and	  ST-­‐11	  were	   the	   only	   STs	   detected	   in	  more	   than	   two	   consecutive	   decades	   based	   on	   the	  sample	  studied.	   In	  contrast,	  82	  (86%)	  STs	  were	  observed	  only	  once,	  7	  (7%)	  twice	  and	  3	  (3%)	   in	   two	   or	   three	   not	   consecutive	   decades.	   Twenty-­‐seven	   percent	   of	   the	   isolates	  belonged	  to	  cc41/44,	  13%	  to	  cc8,	  9%	  to	  cc11,	  8%	  to	  cc32	  and	  7%	  to	  cc269.	  The	  remaining	  36%	   of	   isolates	   included	   17	   different	   clonal	   complexes.	   Ten	   clonal	   complexes	   were	  observed	  only	  once,	  3	  were	  present	  twice,	  whereas	  9	  persisted	  for	  more	  than	  two	  decades	  (Figure	  3.1).	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  Figure	   3.1	   Distribution	   of	   the	   MLST	   clonal	   complexes	   from	   1960	   to	   2008-­‐2009	   in	   the	  Netherlands.	   ‘Other	  cc’	  groups	  together	  12	  less	  frequent	  clonal	  complexes	  (cc5,	  cc22,	  cc35,	  cc103,	  cc162,	  cc1157,	  cc18,	  cc60,	  cc167,	  cc231,	  cc461	  and	  cc334),	  having	  a	  global	  frequency	  inferior	   to	   2%	   of	   the	   entire	   dataset.	   ‘NA	   cc’	   represents	   STs	   without	   a	   clonal	   complex	  assignment.	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  Figure	  3.2	  Distribution	  of	  the	  three	  fHbp	  variants	  Over	  Time.	  
3.4.3 Diversity	  and	  Distribution	  of	  NHBA	  The	   nhba	   gene	   was	   found	   in	   all	   isolates	   considered.	   In	   one	   case	   the	   gene	   presented	   a	  frame-­‐shift	  mutation,	  probably	  causing	  a	   lack	  of	  protein	  expression.	  Forty-­‐eight	  different	  nucleotide	   sequences,	   corresponding	   to	   43	   different	   amino	   acid	   sequences,	   were	  identified.	  NHBA-­‐2	  (24%),	  20	  (22%),	  3	  (6%),	  29	  (6%),	  6	  (5%),	  12	  (4%),	  21	  (4%),	  18	  (3%)	  and	   24	   (3%)	   were	   the	   most	   frequently	   occurring	   (Figure	   3.3B).	   NHBA-­‐2	   (included	   in	  4CMenB)	   was	   predominant	   in	   1960	   (34%),	   1990	   (33%),	   2000	   (43%)	   and	   2008-­‐2009	  (20%),	  whereas	  NHBA-­‐20	  was	  predominant	  in	  1970	  (53%)	  and	  NHBA-­‐29	  in	  1980	  (28%).	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  Figure	  3.3	  Distribution	  of	  protein	  variants	  of	  fHbp	  (A),	  NHBA	  (B)	  and	  NadA	  (C)	  from	  1960	  to	  2008-­‐2009.	  
3.4.5 Association	  of	  fHbp,	  NadA,	  and	  NHBA	  diversity	  with	  MLST	  Clonal	  Complexes	  We	  observed	   clear	   associations	   between	   fHbp,	  NadA,	   and	  NHBA	  unique	   sequences	  with	  clonal	  complexes.	  These	  results,	  also	  obtained	  in	  other	  strain	  panels	  [39],	  were	  based	  on	  a	  standardized	  measure	  of	  association,	   the	  Cramer’s	  V	  coefficient	  (Table	  3.1).	  The	  value	  of	  this	  coefficient	  of	  correlation	  is	  high,	  in	  particular	  for	  fHbp	  and	  NHBA	  (VNHBA = 0.769,	  VfHbp= 0.704	  and	  VNadA = 0.582).	  	  	  








Measure	  of	  the	  
association	  between	  two	  
different	  loci	  
(Standardized	  Index	  of	  
Association§,	  IAS)	  
Measure	  of	  non-­‐
overlapping	  structure	  of	  
combinations	  (f*	  
metrics§)	  
Gene	   Housekeeping	  genes	   fHbp	   nhba	   nadA	   fHbp	   nhba	   nadA	  
fHbp	   0.705	   	   0.371	   0.667	   	   0.284	   0.601	  
nhba	   0.769	   0.371	   	   0.512	   0.284	   	   0.462	  
nadA	   0.582	   0.667	   0.512	   	   0.601	   0.462	   	  §The	  three	  statistical	  parameters	  V,	  IAS	  and	  f*	  are	  based	  on	  the	  frequency	  of	  the	  alleles	  and	  vary	   between	   0	   (random	   distribution)	   and	   1	   (perfect	   association	   or	   non	   overlapping	  distribution	  in	  the	  case	  of	  f*).	  
Table	  3.1	  -­‐	  Associations	  statistics	  between	  different	  loci.	  	  
Several	  sub/variants	  were	  associated	  with	  specific	  clonal	  complexes.	  For	  example,	   fHbp-­‐1.1	  was	  always	  present	  in	  cc32	  isolates.	  Twenty-­‐five	  out	  of	  27	  fHbp-­‐1.14	  were	  present	  in	  cc41/44	   (92%).	   fHbp-­‐2.16	  was	   almost	   always	   represented	   in	   cc8	   isolates	   (91%).	   fHbp-­‐1.15	   and	   fHbp-­‐3.45	   were	   found	  mostly	   in	   cc269	   (80%)	   and	   cc213	   (75%),	   respectively.	  However,	   eleven	   different	   fHbp	   sub/variants	  were	   found	   in	   cc41/44,	   the	  most	   frequent	  being	   fHbp-­‐1.14	   (55%).	   fHbp-­‐2.16	  was	  almost	   always	   represented	   in	   cc8	   isolates.	   Seven	  and	  9	  different	  sub/variants	  were	  represented	  within	  cc11	  and	  cc269,	  respectively.	  Similar	  association	  with	  clonal	  complexes	  was	  observed	  for	  NHBA	  peptides.	  NHBA-­‐3	  was	  always	   present	   (100%)	   in	   cc32,	   NHBA-­‐12	   in	   cc37,	   NHBA-­‐18	   in	   cc213	   and	   NHBA-­‐21	   in	  cc269.	  NHBA-­‐2	  was	  predominant	   in	  cc41/44	  (37	  out	  of	  39	   isolates,	  95%).	  NHBA-­‐29	  was	  found	  mostly	  in	  cc1	  (80%).	  NHBA-­‐20	  was	  the	  most	  frequent	  peptide	  in	  cc8	  (57%),	  even	  if	  it	  was	  also	  present	  in	  cc11	  (32%).	  Also	  NadA	  variants	  were	  associated	  with	  clonal	  complexes.	  NadA-­‐1	  was	  solely	  present	  in	  cc32	  strains.	  NadA-­‐2	  (7	  out	  of	  8	  isolates,	  88%)	  was	  mostly	  present	  in	  cc11	  strains.	  NadA-­‐3	  (81%)	  was	  mostly	  present	  in	  cc8	  strains.	  NadA-­‐5	  was	  solely	  present	  in	  cc213	  strains.	  
3.4.6 Evolution	  of	  cc41/44	  The	  only	  clonal	  complex	  present	  at	  all	  observed	  time	  points	  in	  the	  sample	  was	  cc41/44.	  It	  showed	   a	   shift	   over	   time	   between	   its	   two	   central	   STs	   [80]	   (Figure	   3.4).	   The	   ST-­‐44	   sub-­‐complex	  was	  predominant	  in	  1960-­‐1970,	  and	  ST-­‐41	  was	  prevalent	  after	  1980.	  Still,	  due	  to	  association	  between	  (any)	  protein	  diversity	  and	  MLST,	  a	  trend	  in	  the	  ratio	  of	  fHbp	   variants	   was	   observed	   to	   follow	   changes	   in	   the	   central	   genotypes	   (Figure	   3.4A).	  From	   1960	   to	   1980,	   when	   the	   ST-­‐44	   sub-­‐complex	   was	   predominant,	   fHbp-­‐2	   was	   most	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represented,	  and	  sub/variants	  fHbp-­‐2.24	  and	  2.19	  were	  predominant.	  After	  1980,	  as	  sub-­‐complex	   ST-­‐41	   became	   predominant,	   fHbp-­‐1	   became	   the	   most	   frequent	   variant	   and	  sub/variant	  fHbp-­‐1.14	  predominated	  after	  1990	  (Figure	  3.3A).	  	  
	  Figure	  3.4	  The	  evolution	  of	  cc41/44	  over	  50	  years.	  
Similar	  associations	  with	  each	  of	   the	   two	  sub-­‐complexes	  of	   cc41/44	  were	  also	  observed	  for	  PorA	  and	  FetA	  variants.	  PorA	  P1.7-­‐2,	  4	  and	  FetA	  F1-­‐5	  were	  associated	  with	  the	  ST-­‐41	  sub-­‐complex	   isolates	   collected	   in	   1990	   and	   afterward,	   while	   this	   combination	   was	   not	  observed	  among	  the	  ST-­‐44	  sub-­‐complex	  isolates.	  The	  latter	  was	  more	  heterogeneous	  with	  PorA	  P1.18,	  25-­‐7	  prevalent.	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In	   contrast,	   NHBA-­‐2	   was	   the	   most	   frequently	   occurring	   peptide	   in	   both	   cc41/44	   sub-­‐complexes	  across	  the	  50-­‐year	  period	  examined	  (Figure	  3.4B).	  As	  for	  all	  clonal	  complexes,	  the	  association	  with	  ST-­‐41	  and	  ST-­‐44	  sub-­‐complexes,	  within	  cc41/44,	  was	  evaluated	  using	  Cramer’s	  V	  coefficient.	  NHBA-­‐2	  was	  predominant	  but	  evenly	  distributed	  between	  the	  two	  sub-­‐complexes	   and	   consequently	   NHBA	   did	   not	   show	   a	   relevant	   enrichment	   of	   specific	  peptides	  in	  one	  of	  the	  sub-­‐complexes	  (VNHBA = 0.298).	  In	  contrast,	  the	  overall	  distribution	  of	   the	   fHbp	  sub/variants	   in	  cc41/44	  was	  not	  uniform	  and	  showed	  a	  relevant	  association	  with	  sub-­‐complexes	  (VfHbp = 0.683).	  
3.4.7 Long-­‐term	  Persistence	  of	  Antigen	  Sub/variants	  A	   number	   of	   antigen	   sub/variants	   appeared	   in	   the	   dataset	   only	   once,	   indicating	   a	   low	  frequency	   in	   the	   population.	   This	  might	   suggest	   that	   they	  were	   less	   fit	   and	   excluded	  by	  selection	   over	   time,	   while	   other	   sub/variants	   persisted	   over	   decades.	   Of	   the	   45	   fHbp	  sub/variants	   identified	   in	  the	  current	  sample,	  30	  were	  observed	  once,	  and	  10	  were	  seen	  over	   a	  period	  of	   at	   least	   20	   years.	  Among	   the	  43	  NHBA	  peptides	  observed,	   30	  occurred	  once,	  and	  7	  have	  been	  encountered	  over	  at	  least	  20	  years.	  Eleven	  NadA	  sub/variants	  were	  identified,	  of	  which	  5	  were	  observed	  once	  and	  2	  were	  present	  over	  at	  least	  20	  years.	  The	  proteins	   included	   in	  4CMenB	   (fHbp-­‐1.1	   and	  NadA-­‐3.8)	  were	   observed	  over	   thirty	   years,	  while	  NHBA-­‐2	  was	  observed	  over	  fifty	  years	  (Figure	  3.5).	  In	   general,	   sub/variants	   that	   were	   found	   persisting	   over	   decades	   in	   this	   present	   study	  were	  found	  also	  in	  other	  strain	  panels	  from	  different	  time	  periods	  [18,	  39,	  57].	  Moreover,	  several	  sub/variants	  have	  been	  associated	  over	  time	  also	  with	  different	  clonal	  complexes.	  For	  instance	  fHbp-­‐1.13	  was	  identified	  in	  cc254	  strains	  collected	  during	  1970,	  1980,	  1990	  and	  2008-­‐2009,	  and	  in	  cc60	  strains	  in	  2000.	  fHbp-­‐1.14	  was	  identified	  in	  cc41/44	  isolates	  in	   1990,	   2000	   and	   2008-­‐2009,	   and	   in	   cc254	   isolates	   collected	   in	   2008-­‐2009.	   fHbp-­‐2.16	  was	   found	   in	   cc8	   isolates	   collected	   between	   1970	   and	   2000,	   and	   in	   cc22	   isolates	   from	  2008-­‐2009.NHBA-­‐20	  was	  identified	  in	  cc11	  isolates	  in	  1960,	  1990,	  2000	  and	  2008-­‐2009,	  while	  in	  1970	  and	  1980	  it	  was	  prevalent	  in	  cc8.	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  Figure	   3.5	   	   Persistence	   of	   the	   fHbp	   (a),	   NHBA	   (b)	   and	  NadA	   (c)	   sub/variants	   included	   in	  4CMenB	  vaccine	  formulation.	  
3.4.8 Long-­‐term	  Persistence	  of	  Antigen	  Sub/variant	  Combinations	  Of	  83	  combinations	  of	   fHbp,	  NadA,	  and	  NHBA	  sub/variants,	  most	  were	   found	  only	  once,	  yet	   certain	   combinations	  were	   stable	   and	   persisted	   over	   time.	   Examples	   include:	   fHbp-­‐1.1:NadA-­‐1.1,	  which	  persisted	   for	  30	  years;	  and	   fHbp-­‐2.16:NHBA-­‐20,	  which	  persisted	   for	  40	  years	   (Figure	  3.6).	  The	   relative	  presence	  of	   several	   combinations	   changed	  over	   time.	  For	  example,	  fHbp-­‐2.16:	  NHBA-­‐20	  was	  the	  most	  frequent	  in	  1970,	  fHbp-­‐1.4:NHBA-­‐29	  was	  more	  commonly	  found	  in	  1980,	  and	  fHbp-­‐1.14:NHBA-­‐2	  was	  predominant	  after	  1990.	  In	  addition	  to	  association	  of	  antigens	  sub/variants	  with	  clonal	  complexes,	  several	  antigen	  sub/variant	   combinations	   were	   maintained	   in	   the	   same	   clonal	   complex.	   The	   fHbp-­‐1.1:NadA-­‐1.1	  combination,	  first	  observed	  in	  1980,	  persisted	  in	  all	  isolates	  of	  cc32	  for	  thirty	  years.	   The	   fHbp-­‐1.14:NHBA-­‐2	   combination	   was	   found	   in	   cc41\44	   isolates	   in	   1990	   and	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persisted	  for	  20	  years.	  The	  fHbp-­‐1.4:NHBA-­‐29	  combination	  was	  found	  in	  cc1	  isolates	  from	  1960	   to	   1980.	   The	   fHbp-­‐2.16:NHBA-­‐20:NadA-­‐3.8	   combination	   was	   observed	   in	   cc8	  isolates	  in	  1970	  and	  in	  1980.	  	  
	  Figure	   3.6	   Longevity	   of	   the	   most	   frequent	   combinations	   of	   two	   and	   three	   antigen	  sub/variants.	  
The	  Standardized	  Index	  of	  Association	  IAS	  [94]	  was	  used	  to	  test	  the	  stability	  of	  associations	  between	  pairs	  of	  loci,	  i.e.	  the	  presence	  of	  linkage	  disequilibrium	  (Table	  3.1).	  The	  IAS	  of	  the	  
fHbp	  with	  respect	  to	  nhba	  and	  nadA	  was	  0.371	  and	  0.667	  respectively,	  the	  index	  between	  
nhba	   and	  nadA	  was	  0.512.	  These	   three	  values	   showed	  a	  particular	   faculty	  of	  nadA	   to	  be	  associated	  with	  fHbp	  and	  nhba.	  For	  example,	  these	  rates	  were	  comparable	  with	  the	  same	  index	   calculated	   for	   the	   association	   between	  porA	   VR1	   and	  VR2	   (IAS	   = 0.566),	   two	   very	  close	  loci	  belonging	  to	  the	  same	  gene.	  The	  linkage	  disequilibrium	  between	  the	  fHbp,	  nhba	  and	   nadA	   loci	   showed	   also	   a	   non-­‐overlapping	   structure	   (measured	   by	   f*metrics,	   Table	  3.1).	   The	   non-­‐overlapping	   structure,	   in	   particular	   between	   fHbp	   and	  nadA	   (f*metrics	   =0.601)	  can	  be	  interpreted	  as	  the	  result	  of	  the	  pressure	  of	  selection	  exerted	  by	  the	  immune	  system	  in	  maintaining	  antigenic	  combinations	  in	  the	  neisserial	  population	  [66].	  
3.5 Discussion	  and	  Conclusions	  The	   sequence	   variability	   of	   fHbp,	  NHBA	  and	  NadA	  have	  been	   examined	   in	   several	  strain	   panels	  worldwide	   and	   investigations	   are	   still	   ongoing	   [39][18,	   57].	  We	   evaluated	  prevalence	   and	   sequence	   variations	   of	   fHbp,	   NHBA	   and	   NadA	   in	   a	   panel	   of	   invasive	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meningococcal	   isolates	  collected	   in	   the	  Netherlands	   from	  1960	   to	  2009,	  which,	   is	   to	  our	  knowledge,	  the	  widest	  time	  frame	  of	  any	  collection	  worldwide.	  Among	  the	  meningococci	   isolated	  in	  a	  50	  year	  period	  many	  sub/variants	  of	  each	  antigen	  fHbp,	  NHBA	  and	  NadA	  were	   identified.	  Although	  most	   sub/variants	  were	  observed	  only	  once,	  or	  persistent	  over	  a	  period	  of	  a	  few	  years,	  a	  significant	  number,	  such	  as	  those	  used	  in	  4CMenB,	  were	  observed	  to	  persist	  over	  time.	  Of	  note,	  the	  antigen	  sub/variants	  we	  found	  to	   be	   stable	   and	   conserved	   over	   at	   least	   twenty	   years	   have	   been	   identified	   as	   the	  most	  frequent	  in	  other	  panels	  of	  invasive	  isolates	  [1,	  18,	  39,	  56,	  95-­‐97].	  Short-­‐lived	  sub/variants	  were	   likely	   less	   fit	   or	  occurred	   too	   infrequently	   to	  be	  observed,	  which	  may	   suggest	   that	  they	  were	  excluded	  by	  immune	  selection.	  Associations	   between	   antigen	   sub/variants	   and	   clonal	   complexes	   measured	   by	   the	  Cramer’s	   V	   coefficient,	   a	   standardized	   measure	   of	   association,	   were	   also	   identified	   and	  were	  consistent	  with	  previous	  studies	  in	  other	  strain	  panels	  [39,	  57].	  The	   three	   protein	   sub/variants	   chosen	   for	   inclusion	   in	   4CMenB	   (fHbp-­‐1.1,	   NHBA-­‐2	   and	  NadA-­‐3.8)	   were	   the	   most	   common	   worldwide	   and	   were	   expected	   to	   provide	   cross-­‐reactivity	  [17,	  56,	  98,	  99].	  An	  interesting	  and	  unexpected	  finding	  of	  this	  study	  is	  their	  long-­‐term	   persistence	   in	   the	   current	   strain	   panel,	   which	   was	   thirty	   years	   for	   fHbp-­‐1.1	   and	  NadA-­‐3.8,	  and	  fifty	  years	  for	  NHBA-­‐2.	  Long	  term	  stability	  and	  persistence	  was	  observed	  also	  for	  several	  combinations	  of	  protein	  sub/variants.	  Antigen	  combinations	   showed	  a	  non-­‐overlapping	   structure.	  As	   reported	   in	  literature,	   if	   immune	   selection	   was	   absent	   or	   neutral,	   then	   all	   antigen	   variants	   and	  sub/variants	  would	  occur	   for	   similar	   time	  spans.	  On	   the	  contrary,	   it	  has	  been	  suggested	  that	   selection	   may	   cause	   strong	   linkage	   disequilibrium	   (or	   non-­‐random	   association	   of	  alleles	   at	   the	   different	   loci)	   between	   some	   locus	   pairs	   [48,	   65,	   96].	   As	   observed	   in	   this	  study,	   the	   stability	   and	   persistence	   over	   decades	   of	   discrete	   fHbp,	   NHBA	   and	   NadA	  sub/variants	   and	   non-­‐overlapping	   antigen	   sub/variant	   combinations	   suggest	   they	  were	  maintained	  by	  natural	  selection.	   In	  the	  case	  of	  antigen	  sub/variants,	   the	  persistence	  was	  noticed	   also	   in	   different	   genetic	   environments	   such	   as	   different	   clonal	   complexes.	  Persistent	  antigen	  combinations	  in	  association	  with	  certain	  clonal	  complexes	  may	  indicate	  that	  acquisition	  of	  new	  alleles	  encoding	  antigen	  variants	  may	  impair	  fitness	  of	  that	  clonal	  complex	  [90].	  Our	   observation	   of	   the	   persistence	   of	   the	   antigen	   sub/variants	   in	   4CMenB	   may	   also	  indicate	   that	   the	   vaccine	   will	   be	   able	   to	   provide	   protection	   against	   populations	   of	  meningococci	  over	  time,	  as	  the	  antigens	  they	  target	  have	  tended	  to	  persist.	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We	   used	   the	   Standardized	   Index	   of	   Association	   IAS	   to	   quantify	   the	   extent	   of	   allele	  association	  and	  long-­‐term	  stability	  and	  f*	  metrics	  to	  evidence	  a	  non-­‐overlapping	  structure	  of	  antigen	  combinations.	  Buckee	  and	  colleagues	  first	  used	  this	  parameter	  to	  evaluate	  the	  long-­‐term	  stability	  of	  FetA	  and	  PorA	  combinations	  on	  carried	  meningococci	  [66].	  Given	  the	  novelty	   of	   the	   Buckee	   study,	   our	   results	   contribute	   not	   only	   to	   an	   understanding	   of	  invasive	  meningococcal	  strains	  but	  also	  to	  the	  development	  of	  approaches	  for	  evaluating	  long-­‐term	  stability	  in	  bacterial	  populations	  over	  time.	  In	   the	  cc41/44	  complex,	   the	  predominance	  of	  antigen	  sub/variants	  and	  STs	  shifted	  over	  time.	  This	   clonal	   complex	   is	  of	   additional	  public	  health	   interest	  because	  cc41/44	  strains	  are	  almost	  equally	  often	  isolated	  from	  healthy	  carriers	  and	  from	  cases	  of	  invasive	  disease	  [53,	   89,	   97].	   Recently,	   a	   cc41/44	   outbreak	   in	   the	   city	   of	   Aachen,	   Germany	   and	   3	  neighboring	   counties	   (Greater	   Aachen)	   has	   been	   described	   [89].	   Strains	   of	   cc41/44	   are	  also	  among	  the	  most	  important	  causes	  of	  serogroup	  B	  disease	  in	  the	  USA.	  The	  central	  STs	  of	  cc41/44,	  that	  is	  to	  say	  ST-­‐41	  and	  ST-­‐44,	  are	  putative	   ‘ancestral	  genotypes’	  [80].	  In	  the	  Netherlands	  strain	  collection,	  the	  ST-­‐44	  sub-­‐complex	  was	  predominant	  during	  the	  1960s,	  whereas	  the	  ST-­‐41	  sub-­‐complex	  became	  predominant	  from	  1980	  onwards,	  a	  circumstance	  also	  observed	   in	  Belgium	  [97]	  and	  New	  Zealand	   [53]	   from	  1990	  onwards.	  As	  previously	  published,	   cc41/44	   isolates	   collected	   during	   1980	   and	   later	   harbored	   the	   restriction	  modification	  system	  nmeSI	  [90].	  In	  contrast,	  80%	  of	  the	  isolates	  of	  the	  ST44	  sub-­‐complex	  appeared	   to	   have	   two	   different	   genes	   at	   the	   genomic	   position	   of	   the	   nmeSI	   system	  encoding	   a	   MoxR	   like	   AAA	   ATPase	   and	   a	   protein	   with	   a	   Von	   Willenbrand	   domain,	  respectively	   (data	   not	   shown).	   In	   eBURST	   analyses,	   fHbp	   variant	   distribution	   changed	  with	   the	   relative	   predominance	   of	   the	   ST-­‐44	   and	   ST-­‐41	   sub-­‐complexes.	   In	   1960-­‐1970,	  when	  the	  ST-­‐44	  sub-­‐complex	  was	  predominant,	  fHbp-­‐2	  and	  fHbp-­‐3	  were	  more	  common	  in	  the	   strain	   collection.	   After	   1980	   ST-­‐41	   and	   ST-­‐41	   associated	   fHbp-­‐1	   became	   most	  prevalent.	  Although	  it	  increased	  in	  prevalence	  over	  time,	  fHbp-­‐1	  was	  the	  only	  variant	  that	  was	  present	   in	  both	   sub-­‐complexes	   at	   all	   time	  periods.	  Two	  additional	   surface	  proteins,	  PorA	  and	  FetA	  showed	  a	  similar	  trend	  to	  fHbp.	  NHBA-­‐2,	  the	  most	  frequent	  sub/variant	  in	  cc41/44,	  was	  also	  observed	  in	  both	  sub-­‐complexes	  at	  all	  time	  periods.	  Given	  the	  intrinsic	  potential	   variability	   of	   NHBA,	   the	   maintenance	   of	   the	   same	   sub/variant	   in	   both	   sub-­‐complexes	  over	   fifty	  years,	  despite	   changes	   in	   the	  genotype	  and	   in	   the	  predominance	  of	  the	   other	   protein	   variants,	   could	   be	   a	   consequence	   of	   selective	   pressure	   or	   fitness	  constraints.	  We	   examined	   the	   broadest	   collection	   of	   pathogenic	   meningococcal	   isolates	   over	   the	  longest	   time	   span	   available	   globally.	   Significantly,	   we	   confirmed	   that	   the	   sequence	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conservation	  of	  specific	  fHbp,	  NadA,	  and	  NHBA	  sub/variants	  observed	  across	  strains	  and	  geographic	   regions	   in	   recent	   years	   has	   also	   been	   present	   over	   the	   last	   several	   decades.	  Thus,	   the	   selection	   of	   fHbp,	   NadA,	   and	   NHBA	   as	   antigens	   in	   4CMenB	   is	   supported	   by	  current	   and	   past	   molecular	   epidemiology.	   The	   hypothesis	   that	   the	   stability	   of	   certain	  sub/variants	   and	   combinations	   of	   fHbp,	   NadA,	   and	   NHBA	   likely	   results	   from	   natural	  selection	   also	   supports	   earlier	   interpretations	   that	   these	   proteins	   contribute	   to	  meningococcal	  survival	  and	  pathogenesis	  or	  fitness	  [17,	  95,	  100-­‐102].	  Further,	  our	  results	  may	  help	  to	  support	  the	  long-­‐term	  validity	  of	  fHbp,	  NHBA	  and	  NadA	  characterization	  and	  additional	  typing	  systems	  for	  meningococci	  currently	  being	  implemented.	  Further	  studies	  are	  needed	  in	  order	  to	  verify	  whether	  the	  observations	  in	  this	  strain	  panel	  are	   generalizable.	   To	   our	   knowledge,	   no	   similar	   panels,	   composed	   of	   invasive	  meningococcal	   isolates	   collected	   over	   a	   so	   long	   time	   period,	   exist	   in	   other	   countries.	  Further	   work	   will	   also	   be	   needed	   to	   articulate	   the	   results	   of	   the	   present	   study	   with	  ongoing	   efforts	   to	   evaluate	   the	   clinical	   effects	   and	   evaluation	   of	   the	   strain	   coverage	   of	  4CMenB	   [103].	   The	   Meningococcal	   Antigen	   Typing	   System	   (MATS)	   has	   been	   recently	  described	  as	  a	  qualitative	  and	  quantitative	  assay	  to	  predict	  4CMenB	  vaccine	  coverage.	  This	  assay	   measures	   for	   each	   strain	   the	   expression	   level	   and	   the	   cross-­‐reactivity	   of	   each	  vaccine	  antigen	  [5].	  It	  will	  be	  important	  in	  future	  to	  apply	  MATS	  to	  old	  and	  new	  isolates	  to	  evaluate	   the	   temporal	   dynamics	   of	   changes	   in	   epidemiology	   and	   of	   potential	   antigenic	  shift	   for	   the	   vaccine-­‐target	   antigens	   in	   normal	   condition	   and	   following	   vaccine	  introduction.	  A	   limitation	   of	   the	   present	   study	   is	   that	   it	   comprises	   genetic	   data	   only.	   The	   study	   of	  temporal	  patterns	  of	  genetic	  associations	  among	  vaccine	  protein	  variants	  and	  MLST	  clonal	  complexes	   is	   important,	  even	  if	  as	  an	   initial	  step.	  Also,	  protein	  expression	  was	  evaluated	  for	   genes	   that	   have	   an	   insertion	   or	   a	   frame	   shift	   mutation,	   only.	   As	   protein	   expression	  would	  yield	  even	  greater	  differences	  in	  bactericidal	  titer,	  the	  evaluation	  of	  MATS	  results	  in	  this	  panel	  would	  be	  very	  interesting.	  Another	  limitation	  is	  that	  only	  165	  invasive	  isolates	  randomly	  selected	  were	  tested	  over	  a	  period	  of	   50	   years,	   and	  how	   representative	   are	   the	   selected	   isolates	   could	   appear	   to	   be	  actually	  doubtful.	  However,	  the	  number	  of	  isolates	  for	  each	  clonal	  complex	  indeed	  reflects	  the	   relative	   incidence	   of	   clonal	   complexes	   and	   represents	   a	   substantial	   spectrum	   of	  different	  serogroup	  B	  meningococci	  in	  the	  Netherlands	  over	  the	  last	  decades.	  In	  addition,	  carriage	   isolates	   were	   not	   included.	   Limiting	   selection	   to	   pathogenic	   isolates	   may	   have	  resulted	   in	   the	   over-­‐representation	   of	   hypervirulent	   lineages,	   instead	   of	   a	   more	   even	  balance	   of	   all	   meningococcal	   clones	   [104].	   Moreover,	   we	   cannot	   comment	   on	   the	   two-­‐
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variant	  fHbp	  vaccine	  currently	  in	  clinical	  trials	  because	  only	  one	  of	  the	  two	  variants,	  fHbp-­‐3.45,	   was	   identified	   in	   this	   study.	   Surprisingly,	   only	   four	   isolates	   at	   one	   time	   point	  harbored	  this	  fHbp	  variant,	  whereas	  fHbp-­‐1.55,	  was	  not	  found	  in	  the	  current	  strain	  panel.	  Data	   obtained	   in	   this	   study	   highlight	   the	   importance	   of	   monitoring	   over	   time	   the	  evolutionary	   pattern	   of	   surface	   proteins	   included	   as	   vaccine	   antigens.	   The	   stability	   of	  certain	   sub/variants	   was	   of	   course	   observed	   in	   a	   pre-­‐vaccination	   era,	   therefore	   in	   the	  absence	   of	   a	   strong	   immune	   selection	   against	   the	   three	   antigen	   sub/variants.	   It	  will	   be	  interesting	   to	   monitor	   the	   long-­‐term	   persistence	   even	   after	   the	   introduction	   of	   the	  vaccine.	  Stability	   and	   longevity	   suggest	   that	   several	   fHbp,	   NHBA	   and	   NadA	   sub/variants	   are	  maintained	  by	  selection	  despite	   the	   fact	   that	   recombination	  continuously	  generates	  new	  sub/variants.	   In	   particular,	   the	   long-­‐term	   persistence	   of	   the	   three	   antigen	   sub/variants	  included	  in	  the	  vaccine,	  fHbp-­‐1.1,	  NHBA-­‐2	  and	  NadA-­‐3.8,	  may	  be	  indicative	  for	  long	  term	  broad	  coverage	  of	  4CMenB.	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Appendix	  –	  Supplementary	  Material	  
	  
	  Table	   S1	   The	   complete	   table	   of	   the	   isolates.	   The	   serogroup	   typing	   was	   indicated	   in	  parentheses	  for	  N.	  meningitidis	  strains.	  
	  


























Neisseria_bacilliformis 1 Neisseria_bacilliformis_ATCC_BAA_1200 AFAY00000000 69 28.3 28.3 weak@homology
Neisseria_cinerea_ATCC_14685 ACDY00000000,@ATCC14685@§ 35,@35















Neisseria_cinerea_CCUG5746 CCUG5746@§ 250 89.8 Variant@1 the@locus@is@higly@fragmented@in@multiple@contigs
Neisseria_elongata_glycolytica 1 Neisseria_elongata_glycolytica_ATCC_29315 ADBF00000000 153 31.8 31.8 weak@homology
Neisseria_flavescens_NRL30031_H210 ACEN00000000 117 42 weak@homology 95.5 contig@edge 25.68
Neisseria_flavescens_SK114 ACQV00000000 31 41.2 weak@homology 26.8 weak@homology 24.42
Neisseria_gonorrhoeae_1291 ABZF00000000 175 63 Variant@3 82.4
Neisseria_gonorrhoeae_35_02 ABZG00000000 156 63 Variant@3 82.2
Neisseria_gonorrhoeae_DGI18 ABZH00000000 153 63 Variant@3 82.8
Neisseria_gonorrhoeae_DGI2 ACIG00000000 134 64.9 frameshifted,@Variant@3 82.4
Neisseria_gonorrhoeae_F62 ADAA00000000 134 62.6 Variant@3 82.8
Neisseria_gonorrhoeae_FA_1090 AE004969 1 63 Variant@3 82.8
Neisseria_gonorrhoeae_FA19 ABZJ00000000 168 63 Variant@3 82.2
Neisseria_gonorrhoeae_FA6140 ABZI00000000 161 62.6 Variant@3 82.8
Neisseria_gonorrhoeae_MS11 ABZK00000000 196 64.9 frameshifted,@Variant@3 82.5
Neisseria_gonorrhoeae_NCCP11945 CP001050 1 63 Variant@3 82.4
Neisseria_gonorrhoeae_PID1 ABZM00000000 145 64.5 frameshifted,@Variant@3 62.1 400bp@deletion,@frameshifted
Neisseria_gonorrhoeae_PID18 ABZL00000000 175 64.9 frameshifted,@Variant@3 82.4
Neisseria_gonorrhoeae_PID24_1 ABZN00000000 168 62.6 Variant@3 87.4 contig@edge
Neisseria_gonorrhoeae_PID332 ABZO00000000 168 62.6 Variant@3 82.4
Neisseria_gonorrhoeae_SK_92_679 ABZP00000000 197 62.6 Variant@3 82.2
Neisseria_gonorrhoeae_SK_93_1035 ABZQ00000000 156 62.6 Variant@3 76.5 frameshifted
Neisseria_gonorrhoeae_TCDC_NG08107 CP002440 1 62.6 Variant@3 82.2



























Neisseria_lactamica_8206 8206@§ 574 @in@the@locus@OPA@like@proten@NLA_18150 81.2 contig@edge
Neisseria_macacae 1 Neisseria_macacae_ATCC_33926 AFQE00000000 200 42.6 42.6 weak@homology,@different@locus 39.9 39.9 weak@homology
Neisseria_meningitidis_053442((s.(C) CP000381 1 95.6 Variant@1 87.3
Neisseria_meningitidis_8013((s.(C) FM999788 1 74.7 Variant@2 85.6 99.51
Neisseria_meningitidis_961_5945@(s.@B) AEQK00000000 166 74 Variant@2 84.0 98.75
Neisseria_meningitidis_alpha14((cnl) AM889136 1 71.8 Variant@2 82.2
Neisseria_meningitidis_alpha710((s.(B) CP001561 1 70.3 Variant@2 87.1
Neisseria_meningitidis_ATCC_13091@(s.@B) AEEF00000000 147 74.7 Variant@2 87.7
Neisseria_meningitidis_CU385@(s.@B) AEQJ00000000 47 99.6 Variant@1 90.2 95.58
Neisseria_meningitidis_ES14902@(s.@B) AEQI00000000 47 93.1 Variant@1 84.0 ND frameshifted
Neisseria_meningitidis_FAM18((s.(C) AM421808 1 71.1 Variant@2 82.6 98.99
Neisseria_meningitidis_G2136((s.(B) CP002419 1 74 Variant@2 84.0 100
Neisseria_meningitidis_H44_76((s.(B) AEQZ00000000,@CP002420 46,@1 99.6 Variant@1 91.4
Neisseria_meningitidis_K1207@(s.@C) ADWM00000000 222 93.4 Variant@1 72.3 ND contig@interruption
Neisseria_meningitidis_M01_240013@(s.@B) AEQL00000000 58 73.6 Variant@2 83.3
Neisseria_meningitidis_M01_240149((s.(B) CP002421 1 95.6 Variant@1 100.0
Neisseria_meningitidis_M01_240355((s.(B) CP002422 1 67 Variant@3 82.8 25.31 possible@frameshift
Neisseria_meningitidis_M04_240196((s.(B) CP002423 1 88.3 Variant@1 83.8
Neisseria_meningitidis_M0579@(s.@B) AEQH00000000 30 73.3 Variant@2 100.0
Neisseria_meningitidis_M13399@(s.@B) AEQG00000000 44 64.1 Variant@3 84.7
Neisseria_meningitidis_M6190@(s.@B) AEQF00000000 46 93.8 Variant@1 84.0 ND IS4@insertion
Neisseria_meningitidis_MC58((s.(B) AE002098 1 100 Variant@1 91.4 95.58
Neisseria_meningitidis_N1568@(s.@X) AEQD00000000 112
92.1 frameshifted@but@low@quality@sequence 88.4
Neisseria_meningitidis_NS44@(s.@Y) AEPJ00000000 365 69.7 Variant@2 76.4
Neisseria_meningitidis_NZ_05_33((s.(B) CP002424 1 91.2 Variant@1 100.0
Neisseria_meningitidis_OX99_30304@(s.@B) AEQE00000000 128 73.6 Variant@2 82.6
Neisseria_meningitidis_S0108@(s.@C) ADWN00000000 226 93.4 Variant@1 72.3 ND contig@interruption
Neisseria_meningitidis_WUE_2594((s.(A) FR774048 1 95.6 Variant@1 82.4 100
Neisseria_meningitidis_Z2491((s.(A) AL157959 1 95.6 Variant@1 82.6
Neisseria_mucosa_ATCC_25996 ACDX00000000 67




Neisseria_mucosa_C102 ACRG00000000 23 41.2 weak@homology,@different@locus 21.4 weak@homology
Neisseria_oral_taxon 1 Neisseria_oral_taxon_014_F0314 ADEA00000000 48 29.2 29.2 weak@homology,@different@locus 20.72 20.7
Neisseria_polysaccharea_ATCC_43768 ADBE00000000,@ATCC43768@§ 139,@139 75.4 frameshifted,@Variant@3 87.5
Neisseria_polysaccharea_NS342 AEPH00000000 288 63.2 frameshifted,@Variant@3 85.6
Neisseria_polysaccharea_15883 15883@§ ? 72 Variant@3 82.2
Neisseria_polysaccharea_CCUG18031 CCUG18031@§ 309 75.4 frameshifted,@Variant@3 84.2
Neisseria_polysaccharea_CCUG24845 CCUG24845@§ 292 75.4 frameshifted,@Variant@3 83.9
Neisseria_polysaccharea_CCUG24846 CCUG24846@§ 323 71.1 contig@edge,@Variant@3 83.2 contig@edge
Neisseria_polysaccharea_CCUG27182 CCUG27182@§ 503 75.2 frameshifted,@Variant@3 83.6 contig@edge
Neisseria_shayeganii 1 Neisseria_shayeganii_871 AGAY00000000 112 28.3 28.3 weak@homology
Neisseria_sicca_4320 AEPF00000000 169 40.8 weak@homology 25.8 weak@homology 37.3 37.3 weak@homology
Neisseria_sicca_ATCC_29256 ACKO00000000 61




Neisseria_sicca_DS1 AEPG00000000 455 41.1 weak@homology 28.9 weak@homology 36.8 36.8 weak@homology
Neisseria_subflava 1 Neisseria_subflava_NJ9703 ACEO00000000 63 41.6 41.6 weak@homology 20.3 20.3 weak@homology
Neisseria_wadsworthii 1 Neisseria_wadsworthii_9715 AGAZ00000000 97
Neisseria_weaveri_ATCC_51223 AFWR00000000 40 27.9 weak@homology
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